Title,Authors,Platform,Cited_url,Cited_count,Year
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: ,"I Litvan, JG Goldman, AI Tröster, BA Schmand, D Weintraub, RC Petersen, ...","Movement disorders 27 (3), 349-356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18377346205312407448,1339,2012
A functional role for adult hippocampal neurogenesis in spatial pattern separation,"CD Clelland, M Choi, C Romberg, GD Clemenson, A Fragniere, P Tyers, ...","Science 325 (5937), 210-213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8203654791220108462,1313,2009
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort,"CH Williams-Gray, T Foltynie, CEG Brayne, TW Robbins, RA Barker","Brain 130 (7), 1787-1798",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2542550381978895584,847,2007
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands,"R Cools, RA Barker, BJ Sahakian, TW Robbins","Cerebral cortex 11 (12), 1136-1143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5457664398173150834,845,2001
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease,"AA Kehagia, RA Barker, TW Robbins","The Lancet Neurology 9 (12), 1200-1213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1048023964227195304,736,2010
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study,"T Foltynie, CEG Brayne, TW Robbins, RA Barker","Brain 127 (3), 550-560",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17730315025964454580,721,2004
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort,"CH Williams-Gray, JR Evans, A Goris, T Foltynie, M Ban, TW Robbins, ...","Brain 132 (11), 2958-2969",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17541405238562080742,717,2009
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis,"D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, ...","Neurology 75 (12), 1062-1069",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16936633046097392957,680,2010
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry,"SJG Lewis, A Dove, TW Robbins, RA Barker, AM Owen","Journal of Neuroscience 23 (15), 6351-6356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8973913285539703245,559,2003
"L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease","R Cools, RA Barker, BJ Sahakian, TW Robbins","Neuropsychologia 41 (11), 1431-1441",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7535988380013629055,515,2003
Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach,"SJG Lewis, T Foltynie, AD Blackwell, TW Robbins, AM Owen, RA Barker","Journal of Neurology, Neurosurgery & Psychiatry 76 (3), 343-348",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1738070129423082287,497,2005
Dopaminergic modulation of high‐level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET,"R Cools, E Stefanova, RA Barker, TW Robbins, AM Owen","Brain 125 (3), 584-594",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2797259423753918172,411,2002
Neural transplantation for the treatment of Parkinson's disease,"A Björklund, SB Dunnett, P Brundin, AJ Stoessl, CR Freed, RE Breeze, ...","The Lancet Neurology 2 (7), 437-445",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11991119664530802692,401,2003
Mechanisms of cognitive set flexibility in Parkinson's disease,"R Cools, RA Barker, BJ Sahakian, TW Robbins","Brain 124 (12), 2503-2512",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=999297932407608,397,2001
Microglial activation correlates with severity in Huntington disease: a clinical and PET study,"N Pavese, A Gerhard, YF Tai, AK Ho, F Turkheimer, RA Barker, DJ Brooks, ...","Neurology 66 (11), 1638-1643",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14272121499146508540,350,2006
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease,"AJ Morton, NI Wood, MH Hastings, C Hurelbrink, RA Barker, ES Maywood","Journal of Neuroscience 25 (1), 157-163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=904927955752762415,346,2005
"Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial","S Palfi, JM Gurruchaga, GS Ralph, H Lepetit, S Lavisse, PC Buttery, ...","The Lancet 383 (9923), 1138-1146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11802037973084186118,339,2014
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort,"CH Williams-Gray, SL Mason, JR Evans, T Foltynie, C Brayne, ...","J Neurol Neurosurg Psychiatry 84 (11), 1258-1264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2272204860637133068,333,2013
Microglial activation in presymptomatic Huntington's disease gene carriers,"YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini","Brain 130 (7), 1759-1766",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=265104890201223508,325,2007
Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease,"SJG Lewis, A Slabosz, TW Robbins, RA Barker, AM Owen","Neuropsychologia 43 (6), 823-832",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11791661161787463505,309,2005
The spectrum of nonmotor symptoms in early Parkinson disease,"TK Khoo, AJ Yarnall, GW Duncan, S Coleman, JT O’Brien, DJ Brooks, ...","Neurology 80 (3), 276-281",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5477107061457383861,307,2013
Striatal contributions to working memory: a functional magnetic resonance imaging study in humans,"SJG Lewis, A Dove, TW Robbins, RA Barker, AM Owen","European Journal of Neuroscience 19 (3), 755-760",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16211360468471543840,293,2004
"Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity","RA Barker, T Revesz, M Thom, CD Marsden, P Brown","Journal of Neurology, Neurosurgery & Psychiatry 65 (5), 633-640",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11695490672672991300,279,1998
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study,"AJ Yarnall, DP Breen, GW Duncan, TK Khoo, SY Coleman, MJ Firbank, ...","Neurology 82 (4), 308-316",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16232974847798962898,277,2014
-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease,"R Cools, SJG Lewis, L Clark, RA Barker, TW Robbins","Neuropsychopharmacology 32 (1), 180",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10758299257235479376,276,2007
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease,"RA Barker, J Barrett, SL Mason, A Björklund","The Lancet Neurology 12 (1), 84-91",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=806450119549906104,266,2013
"Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease","A Goris, CH Williams‐Gray, GR Clark, T Foltynie, SJG Lewis, J Brown, ...","Annals of neurology 62 (2), 145-153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18383168219174253042,262,2007
Profile of cognitive progression in early Huntington’s disease,"AK Ho, BJ Sahakian, RG Brown, RA Barker, JR Hodges, MN Ané, ...","Neurology 61 (12), 1702-1706",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9020363549857885163,253,2003
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms,"GW Duncan, TK Khoo, AJ Yarnall, JT O'Brien, SY Coleman, DJ Brooks, ...","Movement disorders 29 (2), 195-202",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5909639741778609672,240,2014
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion,"JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...","Neurology 78 (10), 690-695",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4257122343226906268,236,2012
"Molecular diversity of midbrain development in mouse, human, and stem cells","G La Manno, D Gyllborg, S Codeluppi, K Nishimura, C Salto, A Zeisel, ...","Cell 167 (2), 566-580. e19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14341263401917725185,235,2016
Using executive heterogeneity to explore the nature of working memory deficits in Parkinson’s disease,"SJG Lewis, R Cools, TW Robbins, A Dove, RA Barker, AM Owen","Neuropsychologia 41 (6), 645-654",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16842093289564939256,232,2003
Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis,"AA Kehagia, RA Barker, TW Robbins","Neurodegenerative diseases 11 (2), 79-92",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4168028328098338346,231,2013
RNA velocity of single cells,"G La Manno, R Soldatov, A Zeisel, E Braun, H Hochgerner, V Petukhov, ...","Nature 560 (7719), 494","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12770051809659792139,1991386158901379670",230,2018
The heterogeneity of idiopathic Parkinson's disease,"T Foltynie, C Brayne, RA Barker","Journal of neurology 249 (2), 138-145",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6785647429195776134,219,2002
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease,"A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ...","Proceedings of the National Academy of Sciences 111 (7), 2626-2631",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8651256156241335268,218,2014
The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum,"RA Barker, SB Dunnett, A Faissner, JW Fawcett","Experimental neurology 141 (1), 79-93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5575644920479148448,217,1996
Immune problems in central nervous system cell therapy,"RA Barker, H Widner","NeuroRx 1 (4), 472-481",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10538358943003474462,211,2004
Biomarkers and Parkinson's disease,"AW Michell, SJG Lewis, T Foltynie, RA Barker","Brain 127 (8), 1693-1705",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10413232528177346976,206,2004
Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials,"AW Ashor, J Lara, M Siervo, C Celis-Morales, JC Mathers","PloS one 9 (10), e110034",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4804150443134813133,202,2014
A pathophysiological model of freezing of gait in Parkinson's disease,"SJG Lewis, RA Barker","Parkinsonism & related disorders 15 (5), 333-338",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9447842410646681178,200,2009
Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study,"N Pavese, TC Andrews, DJ Brooks, AK Ho, AE Rosser, RA Barker, ...","Brain 126 (5), 1127-1135",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6745337160342822268,200,2003
Sleep and circadian rhythm regulation in early Parkinson disease,"DP Breen, R Vuono, U Nawarathna, K Fisher, JM Shneerson, AB Reddy, ...","JAMA neurology 71 (5), 589-595",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10922642498163643568,195,2014
"Incidence of early-onset dementias in Cambridgeshire, United Kingdom","L Mercy, JR Hodges, K Dawson, RA Barker, C Brayne","Neurology 71 (19), 1496-1499",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13922454986370652619,189,2008
"Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition","JB Rowe, L Hughes, BCP Ghosh, D Eckstein, CH Williams-Gray, S Fallon, ...","Brain 131 (8), 2094-2105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8974131252942091928,188,2008
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD,"A Pyle, T Foltynie, W Tiangyou, C Lambert, SM Keers, LM Allcock, ...","Annals of neurology 57 (4), 564-567",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17794875609499987091,186,2005
Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington’s disease,"AR Aron, F Schlaghecken, PC Fletcher, ET Bullmore, M Eimer, R Barker, ...","Brain 126 (3), 713-723",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4572682823838450949,186,2003
"The natural history of treated Parkinson's disease in an incident, community based cohort","JR Evans, SL Mason, CH Williams-Gray, T Foltynie, C Brayne, ...","Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1112-1118",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13949523945687610959,184,2011
Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF,"GC O'Keeffe, P Tyers, D Aarsland, JW Dalley, RA Barker, MA Caldwell","Proceedings of the National Academy of Sciences 106 (21), 8754-8759",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17508887077844667308,182,2009
Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort,"SE Winder-Rhodes, JR Evans, M Ban, SL Mason, CH Williams-Gray, ...","Brain 136 (2), 392-399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8503429948776533991,178,2013
Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of ,,"Human molecular genetics 20 (2), 345-353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14989924996084019914,177,2010
The basal ganglia and rule-governed language use: evidence from vascular and degenerative conditions,"CE Longworth, SE Keenan, RA Barker, WD Marslen-Wilson, LK Tyler","Brain 128 (3), 584-596",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13085650383802856522,177,2005
Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease,"CH Williams-Gray, A Hampshire, TW Robbins, AM Owen, RA Barker","Journal of Neuroscience 27 (18), 4832-4838",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5907274910224912963,176,2007
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles,"BR Underwood, D Broadhurst, WB Dunn, DI Ellis, AW Michell, C Vacher, ...","Brain 129 (4), 877-886",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17826087060140497168,173,2006
'The clocks that time us'—circadian rhythms in neurodegenerative disorders,"A Videnovic, AS Lazar, RA Barker, S Overeem","Nature Reviews Neurology 10 (12), 683",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9192419142358667103,171,2014
Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475,"AE Rosser, RA Barker, T Harrower, C Watts, M Farrington, AK Ho, ...","Journal of Neurology, Neurosurgery & Psychiatry 73 (6), 678-685",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4817753657803745525,170,2002
Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment,"SE Lazic, HE Grote, C Blakemore, AJ Hannan, A van Dellen, W Phillips, ...","European Journal of Neuroscience 23 (7), 1829-1838",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12171280537750080992,169,2006
Cell-based therapies for Parkinson disease—past insights and future potential,"RA Barker, J Drouin-Ouellet, M Parmar","Nature Reviews Neurology 11 (9), 492",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14382105353073889838,165,2015
Attentional control in Parkinson's disease is dependent on COMT val,"CH Williams-Gray, A Hampshire, RA Barker, AM Owen","Brain 131 (2), 397-408",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14427600200431519322,163,2008
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study,"M Politis, N Pavese, YF Tai, L Kiferle, SL Mason, DJ Brooks, SJ Tabrizi, ...","Human brain mapping 32 (2), 258-270",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13479484931670594951,162,2011
Cognitive deficits and psychosis in Parkinson’s disease,"CH Williams-Gray, T Foltynie, SJG Lewis, RA Barker","CNS drugs 20 (6), 477-505",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17093404646254685510,161,2006
Decreased hippocampal cell proliferation in R6/1 Huntington's mice,"SE Lazic, H Grote, RJE Armstrong, C Blakemore, AJ Hannan, ...","Neuroreport 15 (5), 811-813",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2973408693253722761,161,2004
A two-stage meta-analysis identifies several new loci for Parkinson's disease,"International Parkinson's Disease Genomics Consortium, ...","PLoS genetics 7 (6), e1002142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=945470202976453904,160,2011
Hypothalamic involvement in Huntington's disease: an ,"M Politis, N Pavese, YF Tai, SJ Tabrizi, RA Barker, P Piccini","Brain 131 (11), 2860-2869",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17246626018953700313,156,2008
Neurodegeneration: a failure of neuroregeneration?,"RJE Armstrong, RA Barker","The Lancet 358 (9288), 1174-1176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12690040278818161862,147,2001
The current clinical management of Huntington's disease,"W Phillips, KM Shannon, RA Barker",Movement disorders: official journal of the Movement Disorder Society 23 (11 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12713453299465492684,145,2008
The utility of the Cambridge Behavioural Inventory in neurodegenerative disease,"C Wedderburn, H Wear, J Brown, SJ Mason, RA Barker, J Hodges, ...","Journal of Neurology, Neurosurgery & Psychiatry 79 (5), 500-503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15815227144567135006,143,2008
Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment,"W Phillips, AJ Morton, RA Barker","Journal of Neuroscience 25 (50), 11564-11576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15753920972373738040,142,2005
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study,"JS Paulsen, JD Long, CA Ross, DL Harrington, CJ Erwin, JK Williams, ...","The Lancet Neurology 13 (12), 1193-1201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5836779021496151907,141,2014
Neural grafting in Parkinson’s disease: problems and possibilities,"P Brundin, RA Barker, M Parmar","Progress in brain research 184, 265-294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2631963851899187966,141,2010
Loss of VPS13C function in autosomal-recessive Parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy,"S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ...","The American Journal of Human Genetics 98 (3), 500-513",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1077149473578846581,137,2016
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s disease,"CH Williams-Gray, A Goris, M Saiki, T Foltynie, DAS Compston, ...","Journal of neurology 256 (3), 493-498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8370062545647466224,137,2009
"Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","JG De Yebenes, B Landwehrmeyer, F Squitieri, R Reilmann, A Rosser, ...","The Lancet Neurology 10 (12), 1049-1057",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8614959921550095584,135,2011
Verbal fluency in Huntington’s disease: a longitudinal analysis of phonemic and semantic clustering and switching,"AK Ho, BJ Sahakian, TW Robbins, RA Barker, AE Rosser, JR Hodges","Neuropsychologia 40 (8), 1277-1284",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7504280265685290826,134,2002
Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study,"JS Paulsen, JD Long, HJ Johnson, EH Aylward, CA Ross, JK Williams, ...","Frontiers in aging neuroscience 6, 78",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14091765586768054897,132,2014
Planning ability in Parkinson's disease is influenced by the COMT val,"T Foltynie, TE Goldberg, SGJ Lewis, AD Blackwell, BS Kolachana, ...",Movement disorders: official journal of the Movement Disorder Society 19 (8 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9640721077405284936,131,2004
Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons,"AD Carri, M Onorati, MJ Lelos, V Castiglioni, A Faedo, R Menon, ...","Development 140 (2), 301-312",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17537677276887651780,130,2013
"Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon","JW Fawcett, RA Barker, SB Dunnett","Experimental brain research 106 (2), 275-282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8962230947321280634,129,1995
Health‐related quality of life in Huntington's disease: Which factors matter most?,"AK Ho, AS Gilbert, SL Mason, AO Goodman, RA Barker","Movement Disorders 24 (4), 574-578",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8103070533948029791,127,2009
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson’s disease,"T Foltynie, B Cheeran, CH Williams-Gray, MJ Edwards, SA Schneider, ...","Journal of Neurology, Neurosurgery & Psychiatry 80 (2), 141-144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2029094638346078860,124,2009
 is not a Parkinson's disease susceptibility gene,"DG Healy, PM Abou‐Sleiman, JP Casas, KR Ahmadi, T Lynch, S Gandhi, ...",Annals of Neurology: Official Journal of the American Neurological …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12656808134023420256,124,2006
Imaging microglial activation in Huntington's disease,"YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini","Brain research bulletin 72 (2-3), 148-151",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9670707748017079957,121,2007
The BDNF Val,"T Foltynie, SGJ Lewis, TE Goldberg, AD Blackwell, BS Kolachana, ...","Journal of neurology 252 (7), 833-838",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5771890957620827290,118,2005
Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function,"AR Aron, L Watkins, BJ Sahakian, S Monsell, RA Barker, TW Robbins","Journal of cognitive neuroscience 15 (5), 629-642",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3452382831069712602,115,2003
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study,"E Mak, L Su, GB Williams, MJ Firbank, RA Lawson, AJ Yarnall, ...","Brain 138 (10), 2974-2986",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2537978057731199236,113,2015
Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study,"C Nombela, JB Rowe, SE Winder-Rhodes, A Hampshire, AM Owen, ...","Brain 137 (10), 2743-2758",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6427206514981033036,113,2014
Dynamic causal modelling of effective connectivity from fMRI: Are results reproducible and sensitive to Parkinson's disease and its treatment?,"JB Rowe, LE Hughes, RA Barker, AM Owen","Neuroimage 52 (3), 1015-1026",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7247397819386915464,112,2010
The metabolic profile of early Huntington's disease-a combined human and transgenic mouse study,"AOG Goodman, PR Murgatroyd, G Medina-Gomez, NI Wood, N Finer, ...","Experimental neurology 210 (2), 691-698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3163670811559324787,111,2008
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington’s disease,"I Reuter, YF Tai, N Pavese, KR Chaudhuri, S Mason, CE Polkey, ...","Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 948-951",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18402745987116048797,108,2008
Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease,"AW Michell, LM Luheshi, RA Barker","Neuroscience letters 381 (3), 294-298",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10344805646107589888,108,2005
The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study,"NZ Hobbs, SMD Henley, GR Ridgway, EJ Wild, RA Barker, RI Scahill, ...","Journal of Neurology, Neurosurgery & Psychiatry 81 (7), 756-763",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6722896682407742499,105,2010
Systematic Review and UK‐Based Study of ,"LL Kilarski, JP Pearson, V Newsway, E Majounie, MDW Knipe, ...","Movement Disorders 27 (12), 1522-1529",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16606970317147325277,104,2012
Defective emotion recognition in early HD is neuropsychologically and anatomically generic,"SMD Henley, EJ Wild, NZ Hobbs, JD Warren, C Frost, RI Scahill, ...","Neuropsychologia 46 (8), 2152-2160",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3021287405160680201,104,2008
Intracellular SERS nanoprobes for distinction of different neuronal cell types,"A Huefner, WL Kuan, RA Barker, S Mahajan","Nano letters 13 (6), 2463-2470",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=497882989444705686,102,2013
White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function,"CL Rae, MM Correia, E Altena, LE Hughes, RA Barker, JB Rowe","Neuroimage 62 (3), 1675-1684",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5779545281776032174,102,2012
GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro,"M Jain, RJE Armstrong, P Tyers, RA Barker, AE Rosser","Experimental neurology 182 (1), 113-123",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=29601869326415964,102,2003
Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines,"GQ Daley, I Hyun, JF Apperley, RA Barker, N Benvenisty, AL Bredenoord, ...","Stem cell reports 6 (6), 787-797",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16924925424253803610,101,2016
The Cambridge behavioural inventory revised,"HJ Wear, CJ Wedderburn, E Mioshi, CH Williams-Gray, SL Mason, ...","Dementia & neuropsychologia 2 (2), 102-107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16208842848736209664,100,2008
Mutant huntingtin is present in neuronal grafts in Huntington disease patients,"F Cicchetti, S Lacroix, G Cisbani, N Vallières, M Saint‐Pierre, I St‐Amour, ...","Annals of neurology 76 (1), 31-42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14051829471751686155,99,2014
Saccadic latency distributions in Parkinson’s disease and the effects of L-dopa,"AW Michell, Z Xu, D Fritz, SJG Lewis, T Foltynie, CH Williams-Gray, ...","Experimental brain research 174 (1), 7-18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14895007969740653183,98,2006
Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment,"PC Nopoulos, EH Aylward, CA Ross, JA Mills, DR Langbehn, HJ Johnson, ...","Brain 134 (1), 137-142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3189537860750076358,96,2010
Cerebrovascular and blood–brain barrier impairments in Huntington's disease: potential implications for its pathophysiology,"J Drouin‐Ouellet, SJ Sawiak, G Cisbani, M Lagacé, WL Kuan, ...","Annals of neurology 78 (2), 160-177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4603349166312089255,95,2015
Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain,"GC O’Keeffe, RA Barker, MA Caldwell","Cell Cycle 8 (18), 2888-2894",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10719376696165848096,94,2009
Habitual versus goal-directed action control in Parkinson disease,"S de Wit, RA Barker, AD Dickinson, R Cools","Journal of Cognitive Neuroscience 23 (5), 1218-1229",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8466881664278734556,92,2011
Clinical translation of stem cells in neurodegenerative disorders,"O Lindvall, RA Barker, O Brüstle, O Isacson, CN Svendsen","Cell stem cell 10 (2), 151-155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1310175967778186898,91,2012
Neurotrophic factors as a therapeutic target for Parkinson's disease,"JR Evans, RA Barker","Expert opinion on therapeutic targets 12 (4), 437-447",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17237991414616200131,91,2008
Human trials of stem cell-derived dopamine neurons for Parkinson’s disease: dawn of a new era,"RA Barker, M Parmar, L Studer, J Takahashi","Cell Stem Cell 21 (5), 569-573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5341699778946820224,90,2017
Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease,"TP Harrower, P Tyers, Y Hooks, RA Barker","Experimental neurology 197 (1), 56-69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6494485864579621746,89,2006
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson’s disease,"AL Cheesman, RA Barker, SJG Lewis, TW Robbins, AM Owen, DJ Brooks","Journal of Neurology, Neurosurgery & Psychiatry 76 (9), 1204-1210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11344754334983621883,89,2005
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life,"RA Lawson, AJ Yarnall, GW Duncan, TK Khoo, DP Breen, RA Barker, ...","Parkinsonism & related disorders 20 (10), 1071-1075",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10672101712652318843,88,2014
The spectrum of cognitive impairment in Lewy body diseases,"JG Goldman, C Williams‐Gray, RA Barker, JE Duda, JE Galvin","Movement Disorders 29 (5), 608-621",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=662750772375354882,88,2014
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls,"P Bianco, R Barker, O Brüstle, E Cattaneo, H Clevers, GQ Daley, ...","The EMBO journal 32 (11), 1489-1495",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8945781140738464523,88,2013
Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study,"H Jokinen, C Ryberg, H Kalska, R Ylikoski, E Rostrup, MB Stegmann, ...","Journal of Neurology, Neurosurgery & Psychiatry 78 (5), 491-496",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2552195107181418727,88,2007
Huntington's disease patients have selective problems with insight,"AK Ho, AOG Robbins, RA Barker","Movement Disorders 21 (3), 385-389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6019569190648615382,88,2006
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease,"G Hudson, M Nalls, JR Evans, DP Breen, S Winder-Rhodes, KE Morrison, ...","Neurology 80 (22), 2042-2048",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8932304621892604030,87,2013
Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells,"RJE Armstrong, TP Harrower, CB Hurelbrink, M McLaughin, EL Ratcliffe, ...","Neuroscience 106 (1), 201-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3754979532182007803,87,2001
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease,"LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ...","Brain 140 (12), 3191-3203",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7593891931917147402,86,2017
Targeting impulsivity in Parkinson’s disease using atomoxetine,"AA Kehagia, CR Housden, R Regenthal, RA Barker, U Müller, J Rowe, ...","Brain 137 (7), 1986-1997",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6960005794685959462,86,2014
The genetic basis of Parkinson's disease,"T Foltynie, S Sawcer, C Brayne, RA Barker","Journal of Neurology, Neurosurgery & Psychiatry 73 (4), 363-370",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4535448336400855947,86,2002
The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease,"RJE Armstrong, CB Hurelbrink, P Tyers, EL Ratcliffe, A Richards, ...","Experimental neurology 175 (1), 98-111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2074936188772267922,86,2002
A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease,"RA Barker, E Ratcliffe, M Mclaughlin, A Richards, SB Dunnett","Journal of Neuroscience 20 (9), 3415-3424",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10125826446769108975,86,2000
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's,"G Liu, B Boot, JJ Locascio, IE Jansen, S Winder‐Rhodes, S Eberly, ...","Annals of neurology 80 (5), 674-685",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11840175392694468465,85,2016
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study,"DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...","The Lancet Neurology 16 (9), 701-711","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4081584192617570508,16716075942018397964",83,2017
Understanding the dopaminergic deficits in Parkinson’s disease: insights into disease heterogeneity,"SJG Lewis, RA Barker","Journal of clinical neuroscience 16 (5), 620-625",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5401462064537314120,82,2009
Cognitive decline and quality of life in incident Parkinson's disease: the role of attention,"RA Lawson, AJ Yarnall, GW Duncan, DP Breen, TK Khoo, ...","Parkinsonism & related disorders 27, 47-53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8770308945726640350,81,2016
Metabolomic analysis of urine and serum in Parkinson’s disease,"AW Michell, D Mosedale, DJ Grainger, RA Barker","Metabolomics 4 (3), 191",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13927180051899623560,79,2008
Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS,"CB Hurelbrink, RJE Armstrong, SB Dunnett, AE Rosser, RA Barker","European Journal of Neuroscience 15 (7), 1255-1266",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12637131169287403136,79,2002
Top–down attentional control in Parkinson's disease: Salient considerations,"R Cools, R Rogers, RA Barker, TW Robbins","Journal of cognitive neuroscience 22 (5), 848-859",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5587687427905868289,78,2010
The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders,"T Rittman, BC Ghosh, P McColgan, DP Breen, J Evans, CH Williams-Gray, ...","J Neurol Neurosurg Psychiatry 84 (5), 544-551",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17439845303268873383,77,2013
Cell replacement therapy for Parkinson's disease,"R Wijeyekoon, RA Barker","Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1792 (7), 688-702",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5994883450328146983,77,2009
Gray and white matter imaging: A biomarker for cognitive impairment in early P arkinson's disease?,"GW Duncan, MJ Firbank, AJ Yarnall, TK Khoo, DJ Brooks, RA Barker, ...","Movement Disorders 31 (1), 103-110",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14517866362352034143,76,2016
The relation between anger and different forms of disgust: Implications for emotion recognition impairments in Huntington's disease,"AJ Calder, J Keane, AW Young, AD Lawrence, S Mason, RA Barker","Neuropsychologia 48 (9), 2719-2729",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2549452997082272203,76,2010
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease,"P Holmans, V Moskvina, L Jones, M Sharma, ...","Human molecular genetics 22 (5), 1039-1049",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10531604637371548215,75,2012
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease,"Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ...","Brain 137 (4), 1145-1155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13644678580251634260,73,2014
Neuropeptide Y and its role in CNS disease and repair,"M Decressac, RA Barker","Experimental neurology 238 (2), 265-272",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5192991532398224885,73,2012
The catechol-O-methyltransferase Val,"K Wu, D O’Keeffe, M Politis, GC O’Keeffe, TW Robbins, SK Bose, ...","Brain 135 (8), 2449-2457",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9802463930284405567,73,2012
Asymptomatic sleep abnormalities are a common early feature in patients with Huntington’s disease,"AOG Goodman, L Rogers, S Pilsworth, CJ McAllister, JM Shneerson, ...","Current neurology and neuroscience reports 11 (2), 211-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3007702336009133758,72,2011
Predictors of punding in Parkinson's disease: results from a questionnaire survey,"AJ Lawrence, AD Blackwell, RA Barker, F Spagnolo, L Clark, MRF Aitken, ...","Movement Disorders 22 (16), 2339-2345",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15989666346074856840,72,2007
Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis,"M Decressac, B Wright, B David, P Tyers, M Jaber, RA Barker, A Gaillard","Hippocampus 21 (3), 233-238",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17012761172997095653,71,2011
Increased thirst and drinking in Huntington's disease and the R6/2 mouse,"NI Wood, AOG Goodman, JMM van der Burg, V Gazeau, P Brundin, ...","Brain research bulletin 76 (1-2), 70-79",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15432791653139707598,71,2008
The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease,"RA Barker, SL Mason, TP Harrower, RA Swain, AK Ho, BJ Sahakian, ...","J Neurol Neurosurg Psychiatry 84 (6), 657-665",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16826919848673571557,69,2013
Pathological considerations in the treatment of Parkinson's disease: More than just a wiring diagram,"CB Hurelbrink, SJG Lewis","Clinical neurology and neurosurgery 113 (1), 1-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7958595837883638312,69,2011
Cell therapy in Huntington disease,"CD Clelland, RA Barker, C Watts","Neurosurgical focus 24 (3-4), E9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8957743853108938523,68,2008
The effects of multidisciplinary rehabilitation in patients with early‐to‐middle‐stage Huntington's disease: a pilot study,"JA Thompson, TM Cruickshank, LE Penailillo, JW Lee, RU Newton, ...","European journal of neurology 20 (9), 1325-1329",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13784421796836646259,66,2013
Prefrontal dopamine levels determine the balance between cognitive stability and flexibility,"SJ Fallon, CH Williams-Gray, RA Barker, AM Owen, A Hampshire","Cerebral Cortex 23 (2), 361-369",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18223102582625521044,66,2012
Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study,"NZ Hobbs, J Barnes, C Frost, SMD Henley, EJ Wild, K Macdonald, ...","American Journal of Neuroradiology 31 (6), 1036-1041",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3729493736463007040,66,2010
Continuing trials of GDNF in Parkinson's disease,RA Barker,"The Lancet Neurology 5 (4), 285-286",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7054170056997661609,66,2006
"Health‐related quality of life in Huntington's disease: a comparison of two generic instruments, SF‐36 and SIP","AK Ho, AOG Robbins, SJ Walters, S Kaptoge, BJ Sahakian, RA Barker",Movement disorders: official journal of the Movement Disorder Society 19 (11 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2048970159428298055,66,2004
Improving response inhibition in Parkinson’s disease with atomoxetine,"Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ...","Biological psychiatry 77 (8), 740-748",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4261891623083538579,65,2015
Vascular parkinsonism: a review of the precision and frequency of the diagnosis,"T Foltynie, R Barker, C Brayne","Neuroepidemiology 21 (1), 1-7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12252285102744500475,65,2002
"The cellular repair of the brain in Parkinson's disease—past, present and future","M Sayles, M Jain, RA Barker","Transplant immunology 12 (3-4), 321-342",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3782727808710176738,64,2004
S erum immune markers and disease progression in an incident P arkinson's disease cohort (ICICLE‐PD),"CH Williams‐Gray, R Wijeyekoon, AJ Yarnall, RA Lawson, DP Breen, ...","Movement Disorders 31 (7), 995-1003",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17532366992016450852,63,2016
Time course of dopamine neuron loss and glial response in the 6‐OHDA striatal mouse model of Parkinson's disease,"SRW Stott, RA Barker","European Journal of Neuroscience 39 (6), 1042-1056",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1362683937098841507,63,2014
"A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts","RA Barker, RA Fricker, DN Abrous, J Fawcett, SB Dunnett","Cell transplantation 4 (2), 173-200",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=386584870319573522,63,1995
The role of tau in the pathological process and clinical expression of Huntington’s disease,"R Vuono, S Winder-Rhodes, R de Silva, G Cisbani, J Drouin-Ouellet, ...","Brain 138 (7), 1907-1918",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8263001732099682963,62,2015
Challenges assessing clinical endpoints in early Huntington disease,"JS Paulsen, C Wang, K Duff, R Barker, M Nance, L Beglinger, D Moser, ...","Movement Disorders 25 (15), 2595-2603",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14345666234391018318,61,2010
Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's disease,"SMD Henley, EJ Wild, NZ Hobbs, C Frost, DG MacManus, RA Barker, ...",Movement disorders: official journal of the Movement Disorder Society 24 (6 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1005309008339680682,61,2009
Targeting Huntingtin expression in patients with Huntington’s Disease,"SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ...",New England Journal of Medicine,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16587346358880405628,59,2019
Coping processes and health‐related quality of life in Parkinson's disease,"RS Bucks, KE Cruise, TC Skinner, AM Loftus, RA Barker, MG Thomas","International Journal of Geriatric Psychiatry 26 (3), 247-255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8774747953740337266,59,2011
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease,"N Malek, MA Lawton, DMA Swallow, KA Grosset, SL Marrinan, N Bajaj, ...","Movement Disorders 31 (10), 1518-1526",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18395873284277996629,58,2016
Sleep deficits but no metabolic deficits in premanifest H untington's disease,"AS Lazar, F Panin, AOG Goodman, SE Lazic, ZI Lazar, SL Mason, ...","Annals of neurology 78 (4), 630-648",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9508466420448399110,58,2015
Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA),"ME Herva, S Zibaee, G Fraser, RA Barker, M Goedert, MG Spillantini","Journal of Biological Chemistry 289 (17), 11897-11905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13346161095030646895,58,2014
The effect of truncated human α-synuclein (1–120) on dopaminergic cells in a transgenic mouse model of Parkinson's Disease,"AW Michell, GK Tofaris, H Gossage, P Tyers, MG Spillantini, RA Barker","Cell transplantation 16 (5), 461-474",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16960607310781509971,58,2007
Dura mater-associated Creutzfeldt–Jakob disease: experience from surveillance in the UK,"CA Heath, RA Barker, TFG Esmonde, P Harvey, R Roberts, P Trend, ...","Journal of Neurology, Neurosurgery & Psychiatry 77 (7), 880-882",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3901087183096552038,58,2006
Successful treatment of stiff man syndrome with intravenous immunoglobulin.,"RA Barker, CD Marsden","Journal of neurology, neurosurgery, and psychiatry 62 (4), 426",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8605860264024995853,58,1997
Weight changes in Huntington's disease,"AO Robbins, AK Ho, RA Barker","European journal of neurology 13 (8), e7-e7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7110019286277588376,57,2006
The case for autoimmunity in the etiology of schizophrenia,"CAW Goldsmith, DP Rogers",Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (6 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12884889453515669638,56,2008
Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease,"RJE Armstrong, P Tyers, M Jain, A Richards, SB Dunnett, AE Rosser, ...","Experimental brain research 151 (2), 204-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9616841369924776775,56,2003
Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age,"LE Annett, EM Torres, DJ Clarke, Y Ishida, RA Barker, RM Ridley, ...","Cell Transplantation 6 (6), 557-569",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17984928989389051166,56,1997
No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening,"A Goris, CH Williams-Gray, T Foltynie, DAS Compston, RA Barker, ...","The American Journal of Human Genetics 78 (6), 1088-1090",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=812647967125449941,55,2006
The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study,"TM Cruickshank, JA Thompson, JF Domínguez D, AP Reyes, M Bynevelt, ...","Brain and behavior 5 (2), e00312","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16792419568343325294,10919806597763786414",54,2015
"Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity","R Perneczky, BCP Ghosh, L Hughes, RHS Carpenter, RA Barker, ...","Neurobiology of disease 43 (1), 79-85",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=872867982004003716,54,2011
Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease,"AA Kehagia, R Cools, RA Barker, TW Robbins","Neuropsychologia 47 (4), 1117-1127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=595017121076992715,54,2009
The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease.,"A Slabosz, SJG Lewis, K Smigasiewicz, B Szymura, RA Barker, AM Owen","Neuropsychology 20 (5), 578",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17183213338305615162,54,2006
Stem cells and neurological disease,"RA Barker, M Jain, RJE Armstrong, MA Caldwell","Journal of Neurology, Neurosurgery & Psychiatry 74 (5), 553-557",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7609719042497993182,54,2003
Substance P and neurodegenerative disorders. A speculative review,R Barker,"Neuropeptides 20 (2), 73-78",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16527684643811324464,54,1991
Gold nanoparticles explore cells: Cellular uptake and their use as intracellular probes,"A Huefner, D Septiadi, BD Wilts, II Patel, WL Kuan, A Fragniere, ...","Methods 68 (2), 354-363",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9174842397576792370,53,2014
The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro,"FR Ali, K Cheng, P Kirwan, S Metcalfe, FJ Livesey, RA Barker, A Philpott","Development 141 (11), 2216-2224",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14554968834329378894,53,2014
Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease,"SMD Henley, EJ Wild, NZ Hobbs, RI Scahill, GR Ridgway, DG MacManus, ...","Journal of neurology 256 (2), 203-212",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18257069586323595891,53,2009
Olfactory abnormalities in Huntington’s disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients,"SE Lazic, AOG Goodman, HE Grote, C Blakemore, AJ Morton, AJ Hannan, ...","Brain research 1151, 219-226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4124786303040784728,53,2007
Deletions at 22q11. 2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data,"KY Mok, U Sheerin, J Simón-Sánchez, A Salaka, L Chester, ...","The Lancet Neurology 15 (6), 585-596",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16911691235745967689,52,2016
Are stem cell-based therapies for Parkinson’s disease ready for the clinic in 2016?,"RA Barker, M Parmar, A Kirkeby, A Björklund, L Thompson, P Brundin","Journal of Parkinson's disease 6 (1), 57-63",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17799224492839190604,52,2016
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson’s disease,"J Drouin-Ouellet, I St-Amour, M Saint-Pierre, J Lamontagne-Proulx, J Kriz, ...",International Journal of Neuropsychopharmacology 18 (6),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17388370876056607817,51,2015
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?,"PC Buttery, RA Barker","Journal of Comparative Neurology 522 (12), 2802-2816",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15299895629058896716,51,2014
Cellular and molecular aspects of striatal development,"M Jain, RJE Armstrong, RA Barker, AE Rosser","Brain research bulletin 55 (4), 533-540",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4591114854707096960,51,2001
Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers,"N Pavese, M Politis, YF Tai, RA Barker, SJ Tabrizi, SL Mason, DJ Brooks, ...","Neurobiology of disease 37 (2), 356-361",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16520268409170930659,50,2010
The use of quantitative oculometry in the assessment of Huntington’s disease,"FR Ali, AW Michell, RA Barker, RHS Carpenter","Experimental brain research 169 (2), 237-245",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4534241681873820126,50,2006
Lewy bodies in Parkinson's disease: protectors or perpetrators?,"TP Harrower, AW Michell, RA Barker","Experimental neurology 195 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7245192069564752340,50,2005
Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat,"R Barker, SB Dunnett","Experimental brain research 101 (3), 365-374",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3898299905196829399,50,1994
Saccadometry: a new tool for evaluating presymptomatic Huntington patients,"CA Antoniades, PME Altham, SL Mason, RA Barker, R Carpenter","Neuroreport 18 (11), 1133-1136",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7958443647820851464,49,2007
Characterization and visualization of vesicles in the endo-lysosomal pathway with surface-enhanced Raman spectroscopy and chemometrics,"A Huefner, WL Kuan, KH Müller, JN Skepper, RA Barker, S Mahajan","ACS nano 10 (1), 307-316",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7598756426338305669,48,2015
Corticobasal degeneration: clinical aspects,"TH Bak, JR Hodges","Handbook of clinical neurology 89, 509-521",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=536756574089986688,48,2008
Cell-based therapies for Parkinson’s disease,"SC Dyson, RA Barker","Expert review of neurotherapeutics 11 (6), 831-844",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4088787999062331737,47,2011
Association of the human leucocyte antigen region with susceptibility to Parkinson's disease,"M Saiki, A Baker, CH Williams-Gray, T Foltynie, RS Goodman, CJ Taylor, ...","Journal of Neurology, Neurosurgery & Psychiatry 81 (8), 890-891",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15739905315034098557,47,2010
Atomoxetine restores the response inhibition network in Parkinson’s disease,"CL Rae, C Nombela, PV Rodríguez, Z Ye, LE Hughes, PS Jones, T Ham, ...","Brain 139 (8), 2235-2248",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12334871123751911851,46,2016
Patients beware: commercialized stem cell treatments on the web,"PL Taylor, RA Barker, KG Blume, E Cattaneo, A Colman, H Deng, ...","Cell Stem Cell 7 (1), 43-49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=288774155533460750,46,2010
"Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases",R Barker,"Reviews in the Neurosciences 7 (3), 187-214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3356328701197026335,45,1996
Molecular and functional definition of the developing human striatum,"M Onorati, V Castiglioni, D Biasci, E Cesana, R Menon, R Vuono, F Talpo, ...","Nature neuroscience 17 (12), 1804",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6680189950543582016,44,2014
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells,"O Cordero-Llana, SA Scott, SL Maslen, JM Anderson, J Boyle, ...","Cell death and differentiation 18 (5), 907",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16769642989985594584,44,2011
The search for a curative cell therapy in Parkinson's disease,"RL Goya, P Tyers, RA Barker","Journal of the neurological sciences 265 (1-2), 32-42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8439776785483119793,44,2008
Functional integration of neural grafts in Parkinson's disease,"RA Barker, SB Dunnett","nature neuroscience 2 (12), 1047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2264660255712863417,44,1999
"Neural repair, transplantation, and rehabilitation","RA Barker, SB Dunnett",Psychology Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14536280177693723065,44,1999
SUBCUTANEOUS APOMORPHINE AS A DIAGNOSTIC-TEST FOR DOPAMINERGIC RESPONSIVENESS IN PARKINSONIAN SYNDROMES,"R Barker, J Duncan, A Lees","Lancet 1 (8639), 675-675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4792586021454015139,44,1989
Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome,"SE Winder‐Rhodes, P Garcia‐Reitböck, M Ban, JR Evans, TS Jacques, ...","Movement Disorders 27 (2), 312-315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10464043163162347813,43,2012
Therapeutic Options in the Treatment of Clozapine‐Induced Sialorrhea,"DP Rogers, JK Shramko",Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (9 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13762671059698129896,43,2000
Respiratory insufficiency due to high anterior cervical cord infarction,"RS Howard, J Thorpe, R Barker, T Revesz, N Hirsch, D Miller, AJ Williams","Journal of Neurology, Neurosurgery & Psychiatry 64 (3), 358-361",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2451685698006844866,43,1998
Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain,"RA Barker, I de Beaufort","Progress in neurobiology 110, 63-73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12121177827347809220,42,2013
"A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts","RA Fricker, RA Barker, JW Fawcett, SB Dunnett","Cell transplantation 5 (6), 599-611",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18015449517415509467,42,1996
The spectrum of clinical features seen with alpha synuclein pathology,"RA Barker, CH Williams‐Gray","Neuropathology and applied neurobiology 42 (1), 6-19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14194243911118028683,41,2016
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson’s disease,"J Zhang, T Rittman, C Nombela, A Fois, I Coyle-Gilchrist, RA Barker, ...","Brain 139 (1), 161-173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7425765322593659950,41,2015
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism,"S Klebe, JL Golmard, MA Nalls, M Saad, AB Singleton, JM Bras, J Hardy, ...","J Neurol Neurosurg Psychiatry 84 (6), 666-673",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13954580036579828042,41,2013
Huntington’s disease: changes in saccades and hand-tapping over 3 years,"CA Antoniades, Z Xu, SL Mason, RHS Carpenter, RA Barker","Journal of neurology 257 (11), 1890-1898",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2436483567355484622,41,2010
The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease,"JB Rowe, L Hughes, CH Williams-Gray, S Bishop, S Fallon, RA Barker, ...","Neurobiology of aging 31 (6), 1064-1068",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17137111086572773981,41,2010
"The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson’s disease, and the effect of chronic treatment with the selective …","WL Kuan, JW Zhao, RA Barker","Psychopharmacology 197 (2), 279-293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17897805977642859916,41,2008
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens,"D Ribeiro, RL Goya, G Ravindran, R Vuono, CL Parish, C Foldi, T Piroth, ...","Neurobiology of disease 49, 118-127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3738822291899819253,40,2013
Modern therapeutic approaches in Parkinson's disease,"SJG Lewis, MA Caldwell, RA Barker","Expert reviews in molecular medicine 5 (10), 1-20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9360688861916330505,40,2003
Repairing the brain in Parkinson's disease: where next?,RA Barker,Movement disorders: official journal of the Movement Disorder Society 17 (2 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11746928747855008662,40,2002
Neuroendocrine abnormalities in Parkinson's disease,"E De Pablo-Fernández, DP Breen, PM Bouloux, RA Barker, T Foltynie, ...","Journal of Neurology, Neurosurgery & Psychiatry 88 (2), 176-185",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8574400280419274200,39,2017
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in P arkinson's disease with clinical and neuroimaging measures,"Z Ye, CL Rae, C Nombela, T Ham, T Rittman, PS Jones, PV Rodríguez, ...","Human brain mapping 37 (3), 1026-1037",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4223505375492088533,39,2016
The use of the Actiwatch–Neurologica,"CB Hurelbrink, SJG Lewis, RA Barker","Journal of neurology 252 (6), 642-647",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13271385291992697923,39,2005
Successful treatment of intractable epilepsia partialis continua with multiple subpial transections,"P Molyneux, R Barker, M Thom, W Van Paesschen, W Harkness, ...","Journal of neurology, neurosurgery, and psychiatry 65 (1), 137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1039869566934386038,39,1998
Thyrotoxic Hashimoto's encephalopathy.,"R Barker, J Zajicek, I Wilkinson","Journal of neurology, neurosurgery, and psychiatry 60 (2), 234",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16099579859774003569,39,1996
Excessive daytime sleepiness and its risk factors in incident Parkinson's disease,"DP Breen, CH Williams-Gray, SL Mason, T Foltynie, RA Barker","J Neurol Neurosurg Psychiatry 84 (2), 233-234",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11436879321393460446,38,2013
How vital is sleep in Huntington’s disease?,"AOG Goodman, RA Barker","Journal of neurology 257 (6), 882-897",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14181705212586210173,38,2010
Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease,"NZ Hobbs, SMD Henley, EJ Wild, KK Leung, C Frost, RA Barker, ...","Neuroimage 47 (4), 1659-1665",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3097812707017702597,38,2009
Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency,"SA Thompson, J Calvin, S Hogg, S Ferdinandusse, RJA Wanders, ...","Journal of Neurology, Neurosurgery & Psychiatry 79 (4), 448-450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17366528784048247267,38,2008
New therapeutic approaches to Parkinson’s disease including neural transplants,"WL Kuan, RA Barker","Neurorehabilitation and neural repair 19 (3), 155-181",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=825188675858334988,38,2005
The AZ of Neurological Practice: a Guide to Clinical Neurology,"RA Barker, N Scolding, D Rowe",Cambridge University Press,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3260373098254807116,1304039583158697927",38,2005
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts,"G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ...","The Lancet Neurology 16 (8), 620-629",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12846690689669975126,37,2017
Dopamine and Huntington’s disease,"LC Schwab, SN Garas, J Drouin-Ouellet, SL Mason, SR Stott, RA Barker","Expert review of neurotherapeutics 15 (4), 445-458","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18115900918382334562,8890749439170418275",37,2015
Developing stem cell therapies for Parkinson’s disease: waiting until the time is right,RA Barker,"Cell Stem Cell 15 (5), 539-542",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3433221830232674285,37,2014
Striatal allografts in patients with Huntington’s disease: impact of diminished astrocytes and vascularization on graft viability,"G Cisbani, TB Freeman, D Soulet, M Saint-Pierre, D Gagnon, M Parent, ...","Brain 136 (2), 433-443",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1931362712875635102,37,2013
Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease,"P McColgan, JR Evans, DP Breen, SL Mason, RA Barker, ...","Movement Disorders 27 (9), 1173-1177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8501099747168070121,37,2012
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations,"WR Galpern, J Corrigan-Curay, AE Lang, J Kahn, D Tagle, RA Barker, ...","The Lancet Neurology 11 (7), 643-650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7337524155901254593,37,2012
Current status of clinical trials of neural transplantation in Parkinson's disease,"JR Evans, SL Mason, RA Barker","Progress in brain research 200, 169-198",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15844396453243317405,37,2012
The search for biomarkers in Parkinson’s disease: a critical review,"CA Antoniades, RA Barker","Expert review of neurotherapeutics 8 (12), 1841-1852",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6865955895240013141,37,2008
Substance P and Parkinson's disease: a causal relationship?,R Barker,"Journal of theoretical biology 120 (3), 353-362",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7250604249935243394,37,1986
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals,"SE Winder-Rhodes, A Hampshire, JB Rowe, JE Peelle, TW Robbins, ...","Neurobiology of aging 36 (3), 1519-1528",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18157546113260830987,36,2015
Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies,"SR Whitworth, AM Loftus, TC Skinner, N Gasson, RA Barker, RS Bucks, ...","Journal of Parkinson's disease 3 (1), 45-53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10647036591029927192,36,2013
Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease,"M Decressac, B Wright, P Tyers, A Gaillard, RA Barker","Experimental neurology 226 (1), 24-32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15776368844343901989,36,2010
Identifying sleep disturbances in Huntington’s disease using a simple disease-focused questionnaire,"AOG Goodman, AJ Morton, RA Barker",PLoS currents 2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9314774948662524813,36,2010
"Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington’s disease","AW Michell, AOG Goodman, AHD Silva, SE Lazic, AJ Morton, RA Barker","Journal of neurology 255 (8), 1145-1152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10874588994647066922,36,2008
Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson’s disease cohort,"CH Williams-Gray, A Goris, T Foltynie, J Brown, M Maranian, A Walton, ...","Journal of Neurology, Neurosurgery & Psychiatry 77 (5), 665-667",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6441993760286876768,36,2006
Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO),"SF Moore, NV Guzman, SL Mason, CH Williams-Gray, RA Barker","Journal of Parkinson's disease 4 (4), 671-676",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9663403550029512559,35,2014
Juvenile huntington's disease: and other Trinucleotide repeat disorders,O Quarrell,Oxford University Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18374898819495874596,35,2009
Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation,"CB Hurelbrink, RJE Armstrong, LM Luheshi, SB Dunnett, AE Rosser, ...","Experimental neurology 171 (1), 46-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12906654014854547703,35,2001
Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease,"CB Hurelbrink, RJE Armstrong, RA Barker, SB Dunnett, AE Rosser","Cell transplantation 9 (6), 743-749",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6976589207881231987,35,2000
RETRACTED: Effect of electropulsing treatment and ultrasonic striking treatment on the mechanical properties and microstructure of biomedical ti-6Al-4V alloy,"X Ye, Y Ye, G Tang","Journal of the mechanical behavior of biomedical materials 40, 287-296",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13806058805144355003,34,2014
Impaired dimensional selection but intact use of reward feedback during visual discrimination learning in Parkinson's disease,"R Swainson, D SenGupta, T Shetty, LHA Watkins, BA Summers, ...","Neuropsychologia 44 (8), 1290-1304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14839733981249552114,34,2006
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy,"T Rittman, M Rubinov, PE Vértes, AX Patel, CE Ginestet, BCP Ghosh, ...","Neurobiology of aging 48, 153-160",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9931541519069295521,33,2016
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?,"F Cicchetti, RA Barker","Frontiers in pharmacology 5, 139",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7461594888304313150,33,2014
Determinants of delayed diagnosis in Parkinson’s disease,"DP Breen, JR Evans, K Farrell, C Brayne, RA Barker","Journal of neurology 260 (8), 1978-1981",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17653373188140083322,33,2013
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease,"RA Lawson, AJ Yarnall, GW Duncan, DP Breen, TK Khoo, ...","J Neurol Neurosurg Psychiatry 88 (8), 648-652",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8228492464607784902,32,2017
The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias,"WL Kuan, R Lin, P Tyers, RA Barker","Neurobiology of disease 25 (3), 594-608",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6522170438496581966,32,2007
A case of late onset sporadic Parkinson’s disease with an A53T mutation in α-synuclein,"AW Michell, RA Barker, R Raha-Chowdhury, SK Raha","Journal of Neurology, Neurosurgery & Psychiatry 76 (4), 596-597",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9154634326407343177,32,2005
Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's …,"CB Hurelbrink, P Tyers, RJE Armstrong, SB Dunnett, RA Barker, ...","Cell transplantation 12 (7), 687-695",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14272052393636116599,32,2003
Strategies for bringing stem cell-derived dopamine neurons to the clinic: a European approach (STEM-PD),"A Kirkeby, M Parmar, RA Barker","Progress in brain research 230, 165-190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12454838832651408955,31,2017
A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease,"JC Villaescusa, B Li, EM Toledo, PR di Val Cervo, S Yang, SRW Stott, ...","The EMBO journal 35 (18), 1963-1978",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=378847772462277192,31,2016
Gaucher disease and comorbidities: B‐cell malignancy and parkinsonism,"TM Cox, BE Rosenbloom, RA Barker","American journal of hematology 90, S25-S28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9156694539340669101,31,2015
The incidence of Parkinson's disease in the North-East of England,"GW Duncan, TK Khoo, SY Coleman, C Brayne, AJ Yarnall, JT O'Brien, ...","Age and ageing 43 (2), 257-263",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13182416267188435715,31,2013
Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferation,"RL Goya, R Busch, R Mathur, AJ Coles, RA Barker","Neurobiology of Disease 41 (2), 407-414",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11527985454893510889,31,2011
Emerging drug therapies in Huntington's disease,"SL Mason, RA Barker","Expert opinion on emerging drugs 14 (2), 273-297",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3821129565362335848,31,2009
The future of cell-based transplantation therapies for neurodegenerative disorders,"SE Lazic, RA Barker","Journal of hematotherapy & stem cell research 12 (6), 635-642",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1578740234181473648,31,2003
Neural tissue xenotransplantation: what is needed prior to clinical trials in Parkinson's disease?,"RA Barker, AL Kendall, H Widner, Neural Tissue Xenografting Project","Cell transplantation 9 (2), 235-246",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17737464901630308877,31,2000
G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson’s disease,"RA Barker, L Studer, E Cattaneo, J Takahashi","NPJ Parkinson's disease 1, 15017",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15024161547226559273,30,2015
Microangiopathy of the brain and retina with hearing loss in a 50 year old woman: extending the spectrum of Susac’s syndrome,"RA Barker, JR Anderson, P Meyer, DJ Dick, NJ Scolding","Journal of Neurology, Neurosurgery & Psychiatry 66 (5), 641-643",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3687047159661152755,30,1999
Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease,"R Lakshminarayana, D Wang, D Burn, KR Chaudhuri, C Galtrey, ...","npj Parkinson's Disease 3 (1), 2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12891714653279741777,29,2017
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross‐sectional study of iron‐related magnetic resonance imaging susceptibility,"A Martin‐Bastida, NP Lao‐Kaim, C Loane, M Politis, AA Roussakis, ...","European journal of neurology 24 (2), 357-365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17926580033712847917,29,2017
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease,"DP Breen, C Nombela, R Vuono, PS Jones, K Fisher, DJ Burn, DJ Brooks, ...","Movement Disorders 31 (7), 1062-1066",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6699452544162306197,29,2016
Mild cognitive impairment and Parkinson’s disease-something to remember,"RA Barker, CH Williams-Gray","Journal of Parkinson's disease 4 (4), 651-656",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4496285628819781724,29,2014
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study,"MJ Firbank, AJ Yarnall, RA Lawson, GW Duncan, TK Khoo, GS Petrides, ...","J Neurol Neurosurg Psychiatry 88 (4), 310-316",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14377946931934172422,28,2017
Stem cells and the treatment of Parkinson's disease,"F Ali, SRW Stott, RA Barker","Experimental neurology 260, 3-11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9623966994814127312,28,2014
Linked clinical trials–the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments,"P Brundin, RA Barker, PJ Conn, TM Dawson, K Kieburtz, AJ Lees, ...","Journal of Parkinson's disease 3 (3), 231-239",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2664606470013572447,28,2013
Graft-induced dyskinesias in Parkinson's disease: what is it all about?,"RA Barker, WL Kuan","Cell Stem Cell 7 (2), 148-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16199998763865918330,28,2010
The effects of modafinil on mood and cognition in Huntington’s disease,"AD Blackwell, NS Paterson, RA Barker, TW Robbins, BJ Sahakian","Psychopharmacology 199 (1), 29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4311137260854999754,28,2008
Posterior communicating artery aneurysm presenting with haemorrhage into an arachnoid cyst,"RA Barker, RR Phillips, IF Moseley, WJ Taylor, ND Kitchen, JW Scadding","Journal of Neurology, Neurosurgery & Psychiatry 64 (4), 558-560",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5441700492609677778,28,1998
The biology and behaviour of intracerebral adrenal transplants in animals and man,"R Barker, S Dunnett","Reviews in the Neurosciences 4 (2), 113-146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8327459822257970735,28,1993
New approaches for brain repair—from rescue to reprogramming,"RA Barker, M Götz, M Parmar","Nature 557 (7705), 329-334",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12809989421690367029,27,2018
Aberrant nigral diffusion in Parkinson's disease: a longitudinal diffusion tensor imaging study,"C Loane, M Politis, Z Kefalopoulou, N Valle‐Guzman, G Paul, H Widner, ...","Movement Disorders 31 (7), 1020-1026",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8763807263226413300,27,2016
Quality of life and mild cognitive impairment in early parkinson’s disease: does subtype matter?,"RA Lawson, AJ Yarnall, GW Duncan, TK Khoo, DP Breen, RA Barker, ...","Journal of Parkinson's disease 4 (3), 331-336",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11416443885790495892,27,2014
Tau acts as an independent genetic risk factor in pathologically proven PD,"G Charlesworth, S Gandhi, JM Bras, RA Barker, DJ Burn, PF Chinnery, ...","Neurobiology of aging 33 (4), 838. e7-838. e11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9680744368063880869,27,2012
A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial complex I activity,"WL Kuan, E Poole, M Fletcher, S Karniely, P Tyers, M Wills, RA Barker, ...","Journal of Experimental Medicine 209 (1), 1-10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3276901950867158011,27,2012
Biomarkers in Huntington's and Parkinson's Disease,"GC O’Keeffe, AW Michell, RA Barker","Annals of the New York Academy of Sciences 1180 (1), 97-110",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14295986509607110682,27,2009
The basal ganglia and pain,RA Barker,"International journal of neuroscience 41 (1-2), 29-34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9525220076749459703,27,1988
Hippocampal dysfunction defines disease onset in Huntington's disease,"F Begeti, LC Schwab, SL Mason, RA Barker","J Neurol Neurosurg Psychiatry 87 (9), 975-981",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11077808219829467520,26,2016
Parkinson's disease and healthy aging: Independent and interacting effects on action selection,"LE Hughes, RA Barker, AM Owen, JB Rowe","Human brain mapping 31 (12), 1886-1899",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9667477233445474173,26,2010
The future of cell therapies in the treatment of Parkinson's disease,"R Laguna Goya, WL Kuan, RA Barker","Expert opinion on biological therapy 7 (10), 1487-1498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4112671046778511384,26,2007
Migration and differentiation of transplanted human neural precursor cells,"M Jain, RJE Armstrong, S Elneil, AE Rosser, RA Barker","Neuroreport 14 (9), 1257-1262",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=797349204547159669,26,2003
Prospects for the treatment of Parkinson’s disease using neurotrophic factors,"CB Hurelbrink, RA Barker","Expert opinion on pharmacotherapy 2 (10), 1531-1543",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16190095797548023387,26,2001
Advancing pharmacotherapy for treating Huntington’s disease: a review of the existing literature,"SL Mason, RA Barker","Expert opinion on pharmacotherapy 17 (1), 41-52",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17083174359061378581,25,2016
The role of the amygdala during emotional processing in Huntington's disease: From pre-manifest to late stage disease,"SL Mason, J Zhang, F Begeti, NV Guzman, AS Lazar, JB Rowe, ...","Neuropsychologia 70, 80-89",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2031247295063894161,25,2015
Animal models of neurodegenerative diseases,"W Phillips, A Michell, H Pruess, RA Barker","Neural Cell Transplantation, 137-155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16664652094541728318,25,2009
Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease,"AE Rosser, RA Barker, RJE Armstrong, S Elneil, M Jain, CB Hurelbrink, ...","Cell transplantation 12 (7), 679-686",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14385386984107449077,25,2003
Parkinson's disease: an autoimmune process,"RA Barker, AP Cahn","International journal of neuroscience 43 (1-2), 1-7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17921429800264362923,25,1988
Tracking Parkinson’s: study design and baseline patient data,"N Malek, D Swallow, KA Grosset, MA Lawton, SL Marrinan, AC Lehn, ...","Journal of Parkinson's disease 5 (4), 947-959",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3237536311727978532,24,2015
Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions,"LE Hughes, E Altena, RA Barker, JB Rowe","Cerebral Cortex 23 (7), 1572-1581",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15250520338633660695,24,2012
The current status of neural grafting in the treatment of Huntington’s disease. A review,RA Barker,"Frontiers in integrative neuroscience 5, 78",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7091050041938441639,23,2011
SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report,"A Wilkins, JM Brown, RA Barker",Movement disorders: official journal of the Movement Disorder Society 19 (5 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11334065155986464110,23,2004
Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion,"NC Silver, RA Barker, DG MacManus, GJ Barker, M Thom, DGT Thomas, ...","Journal of neurology 244 (3), 204-207",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2480198116140838099,23,1997
Substance P and multiple sclerosis,"R Barker, A Larner","Medical hypotheses 37 (1), 40-43",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3454799945748258777,23,1992
REST suppression mediates neural conversion of adult human fibroblasts via microRNA‐dependent and‐independent pathways,"J Drouin‐Ouellet, S Lau, PL Brattås, DR Ottosson, K Pircs, DA Grassi, ...","EMBO molecular medicine 9 (8), 1117-1131",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11197460765325553906,22,2017
Intra‐and inter‐network functional alterations in P arkinson's disease with mild cognitive impairment,"LR Peraza, D Nesbitt, RA Lawson, GW Duncan, AJ Yarnall, TK Khoo, ...","Human brain mapping 38 (3), 1702-1715",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17258496464267562501,22,2017
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin'Sticks test in patients with Parkinson's disease,"M Lawton, MTM Hu, F Baig, C Ruffmann, E Barron, DMA Swallow, ...","Parkinsonism & related disorders 33, 96-101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6489479581076230190,22,2016
Development and external validation of a prognostic model in newly diagnosed Parkinson disease,"DC Velseboer, RMA de Bie, L Wieske, JR Evans, SL Mason, T Foltynie, ...","Neurology 86 (11), 986-993",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4087485969774263379,22,2016
"Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?","N Quinn, RA Barker, GK Wenning","Clinical Pharmacology & Therapeutics 83 (5), 663-665",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15095338727076596173,22,2008
Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease,"M Jain, RJE Armstrong, S Elneil, RA Barker","Cell transplantation 15 (7), 579-593",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12099987920125017843,22,2006
Visual hallucinations associated with zonisamide,"CI Akman, HP Goodkin, DP Rogers, JJ Riviello Jr",Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (1 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3090886046754426374,22,2003
"Modelling of a targeted nanotherapeutic ‘stroma’to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic …","JW Zhao, SC Dyson, C Kriegel, P Tyers, X He, TM Fahmy, SM Metcalfe, ...","Disease models & mechanisms 7 (10), 1193-1203","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5256888609625912859,5769503240277661147",21,2014
Predictors of Parkinson's disease dementia: towards targeted therapies for a heterogeneous disease,"SF Moore, RA Barker","Parkinsonism & related disorders 20, S104-S107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10348383551076324073,21,2014
"A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.","HORIZON Investigators of the Huntington Study Group, ...","JAMA neurology 70 (1), 25",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14337787372937113282,21,2013
Deep brain stimulation: eye movements reveal anomalous effects of electrode placement and stimulation,"CA Antoniades, P Buttery, JJ FitzGerald, RA Barker, RHS Carpenter, ...","PLoS One 7 (3), e32830",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18296896358290515590,21,2012
Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis,"DP Rogers, CAW Goldsmith","Expert review of neurotherapeutics 9 (1), 47-54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1538615116391282636,21,2009
Neurogenesis in diseases of the central nervous system,"W Phillips, AW Michell, RA Barker","Stem cells and development 15 (3), 359-379",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1049194912065249991,21,2006
Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease,"A Di Pardo, E Amico, A Basit, A Armirotti, P Joshi, MD Neely, R Vuono, ...","Scientific reports 7 (1), 5280",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1712874355476412439,20,2017
Non-dopamine lesions in Parkinson's disease,"G Halliday, RA Barker, DB Rowe",Oxford University Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17117174519406882569,20,2010
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression,"M Lawton, Y Ben-Shlomo, MT May, F Baig, TR Barber, JC Klein, ...","J Neurol Neurosurg Psychiatry 89 (12), 1279-1287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8122013854436874505,19,2018
Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease,"NNW Dissanayaka, RA Lawson, AJ Yarnall, GW Duncan, DP Breen, ...","Parkinsonism & related disorders 36, 63-68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15663201021232562395,19,2017
Diagnostic potential of saccadometry in progressive supranuclear palsy,"CA Antoniades, TH Bak, RHS Carpenter, JR Hodges, RA Barker","Future Medicine Ltd 1 (4), 487-490",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5994081577992907902,19,2007
Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease,"W Phillips, AJ Morton, RA Barker","Neuroreport 17 (15), 1623-1627",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=238022719478745592,19,2006
"Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease","S Palfi, JM Gurruchaga, H Lepetit, K Howard, GS Ralph, S Mason, ...","Human Gene Therapy Clinical Development 29 (3), 148-155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=376083741034708122,18,2018
Rating apathy in Huntington's disease: Patients and companions agree,"S Mason, RA Barker","Journal of Huntington's disease 4 (1), 49-59",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6397422791595898769,18,2015
Mild cognitive impairment in Parkinson's disease: millstone or milestone?,"DJ Burn, RA Barker","Practical neurology 13 (2), 68-69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=874217117860319380,18,2013
Rate and acceleration of whole‐brain atrophy in premanifest and early Huntington's disease,"EJ Wild, SMD Henley, NZ Hobbs, C Frost, DG MacManus, RA Barker, ...","Movement disorders 25 (7), 888-895",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5007865945293029397,18,2010
"Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study","R Reilmann, A McGarry, ID Grachev, JM Savola, B Borowsky, E Eyal, ...","The Lancet Neurology 18 (2), 165-176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10443899348099687208,17,2019
Stem cells and neurodegenerative diseases: where is it all going?,RA Barker,"Regenerative medicine 7 (6s), 26-31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11762801959670329254,17,2012
Parkinson's disease and growth factors–are they the answer?,RA Barker,"Parkinsonism & related disorders 15, S181-S184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5768157953500615305,17,2009
Investigation of ,"A Goris, CH Williams-Gray, T Foltynie, J Brown, M Maranian, A Walton, ...","Journal of neurology 254 (7), 846",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1991932426376447580,17,2007
How does the brain control its own activity? A new function for the basal ganglia,R Barker,"Journal of theoretical biology 131 (4), 497-507",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16530065911522091219,17,1988
Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study,"N Malek, RS Weil, C Bresner, MA Lawton, KA Grosset, M Tan, N Bajaj, ...","J Neurol Neurosurg Psychiatry 89 (7), 702-709","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=902137343168088920,9718784853916113621",16,2018
Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson’s disease,"AM Loftus, RS Bucks, M Thomas, R Kane, C Timms, RA Barker, N Gasson","Journal of the International Neuropsychological Society 21 (2), 137-145",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10998801166282508865,16,2015
Stem cell therapies for Parkinson's disease: are trials just around the corner?,"J Drouin-Ouellet, RA Barker","Regenerative medicine 9 (5), 553-555",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17680853169514403844,16,2014
Parkinson's disease–the continuing search for biomarkers,"DP Breen, AW Michell, RA Barker","Clinical chemistry and laboratory medicine 49 (3), 393-401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14136938743928668102,16,2011
Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.,"AOG Goodman, RA Barker",PLoS currents 3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3582487123079119047,16,2011
Neural transplantation in Huntington's disease: the NEST-UK donor tissue microbiological screening program and review of the literature,"M Farrington, TG Wreghitt, AML Lever, SB Dunnett, AE Rosser, RA Barker","Cell transplantation 15 (4), 279-294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2568954629362228012,16,2006
Random number generation in patients with symptomatic and presymptomatic Huntington's disease,"AK Ho, BJ Sahakian, TW Robbins, RA Barker","Cognitive and behavioral neurology 17 (4), 208-212",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17161202861624752210,16,2004
A case of unilateral neglect in Huntington’s disease,"AK Ho, T Manly, PJ Nestor, BJ Sahakian, TH Bak, TW Robbins, ...","Neurocase 9 (3), 261-273",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14848326358268206070,16,2003
Prospects for the treatment of Parkinson’s disease using neural grafts,RA Barker,"Expert opinion on pharmacotherapy 1 (5), 889-902",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11451231280639636397,16,2000
"Huntingtin aggregation impairs autophagy, leading to Argonaute-2 accumulation and global microRNA dysregulation","K Pircs, R Petri, S Madsen, PL Brattås, R Vuono, DR Ottosson, I St-Amour, ...","Cell reports 24 (6), 1397-1406",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11667730087130492097,15,2018
Direct neuronal reprogramming for disease modeling studies using patient-derived neurons: what have we learned?,"J Drouin-Ouellet, K Pircs, RA Barker, J Jakobsson, M Parmar","Frontiers in neuroscience 11, 530",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16405228545521249948,15,2017
Neural grafting for Parkinson's disease: challenges and prospects,"TB Stoker, NF Blair, RA Barker","Neural regeneration research 12 (3), 389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15678326955210442091,15,2017
The Addenbrooke’s Cognitive Examination-Revised accurately detects cognitive decline in Huntington’s disease,"F Begeti, AYK Tan, GA Cummins, LM Collins, NV Guzman, SL Mason, ...","Journal of neurology 260 (11), 2777-2785",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13267742696979833667,15,2013
Current pharmacological management in juvenile Huntington’s disease,"L Robertson, H Santini, KL O'Donovan, F Squitieri, RA Barker, ...",PLoS currents 4,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17758408389007409607,8970009383071047842",15,2012
Established and emerging therapies for Huntington's disease,"BLC Wright, RA Barker","Current molecular medicine 7 (6), 579-587",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9255431530678370925,15,2007
Increased capacity for axonal outgrowth using xenogenic tissue in vitro and in a rodent model of Parkinson's disease,"WL Kuan, CB Hurelbrink, RA Barker","Xenotransplantation 13 (3), 233-247",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16582248830565909033,15,2006
Fetal porcine dopaminergic cell survival in vitro and its relationship to embryonic age,"RA Barker, E Ratcliffe, A Richards, SB Dunnett","Cell transplantation 8 (6), 593-599",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18159826573985113197,15,1999
Nigral and striatal neurons,"R Barker, A Johnson","Neural cell culture. A practical approach, 25-39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12603681882481100871,15,1995
Emerging treatment approaches for Parkinson's disease,"TB Stoker, KM Torsney, RA Barker","Frontiers in Neuroscience 12, 693",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17180102676161319099,14,2018
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC …,"DMA Swallow, MA Lawton, KA Grosset, N Malek, J Klein, F Baig, ...","J Neurol Neurosurg Psychiatry 87 (11), 1183-1190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17527261981679734717,14,2016
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function,"WL Kuan, N Bennett, X He, JN Skepper, N Martynyuk, R Wijeyekoon, ...","Experimental neurology 285, 72-81",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1848292032141007986,14,2016
Variation in recent onset Parkinson’s disease: implications for prodromal detection,"D Swallow, MA Lawton, KA Grosset, N Malek, CR Smith, NP Bajaj, ...","Journal of Parkinson's disease 6 (2), 289-300",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4912958769309451548,14,2016
Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease,"ML Choi, F Begeti, JH Oh, SY Lee, GC O'Keeffe, CD Clelland, P Tyers, ...","Neurobiology of disease 66, 19-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7142911021564975667,14,2014
How often does music and rhythm improve patients’ perception of motor symptoms in Parkinson’s disease?,"C Nombela, CL Rae, JA Grahn, RA Barker, AM Owen, JB Rowe","Journal of neurology 260 (5), 1404-1405",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2356904336297348865,14,2013
The factor structure of the UPDRS as an index of disease progression in Parkinson's disease,"JR Evans, SL Mason, CH Williams-Gray, T Foltynie, M Trotter, RA Barker","Journal of Parkinson's disease 1 (1), 75-82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2440591025847762387,14,2011
Migration of cells from primary transplants of allo‐and xenografted foetal striatal tissue in the adult rat brain,"CB Hurelbrink, RA Barker","European Journal of Neuroscience 21 (6), 1503-1510",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11693891053057064538,14,2005
Pseudo-neglect in Huntington's disease correlates with decreased angular gyrus density,"AK Ho, PJ Nestor, GB Williams, JL Bradshaw, BJ Sahakian, TW Robbins, ...","Neuroreport 15 (6), 1061-1064",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16653063200990333971,14,2004
Neuroanatomy and Neuroscience at a Glance,"RA Barker, F Cicchetti, ESJ Robinson",John Wiley & Sons,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9431809194388251304,13,2017
"Comparability: manufacturing, characterization and controls, report of a UK regenerative medicine platform pluripotent stem cell platform workshop, trinity hall, cambridge, 14 …","DJ Williams, R Archer, P Archibald, I Bantounas, R Baptista, R Barker, ...","Regenerative medicine 11 (5), 483-492",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=734300631900742730,13,2016
Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: The role of rule reconfiguration,"AA Kehagia, RA Barker, TW Robbins","Journal of neuropsychology 8 (1), 53-74",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17213752765905947685,13,2014
Pax7 expression in the adult rat superior colliculus following optic nerve injury,"MG Thomas, RA Barker, LD Beazley, MR Ziman","Neuroreport 18 (2), 105-109",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5140391208049406096,13,2007
Is there a future for neural transplantation?,"TP Harrower, RA Barker","BioDrugs 18 (3), 141-153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14068515011194414959,13,2004
"Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue","TP Harrower, A Richards, G Cruz, L Copeman, SB Dunnett, RA Barker","Xenotransplantation 11 (1), 60-71",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9820400313588035708,13,2004
Porcine neural xenografts: what are the issues?,RA Barker,"Novartis Foundation symposium, 184-201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5120394835371269074,13,2000
Environmental toxins and Parkinson's disease,R Barker,"Trends in Neurosciences 12 (5), 182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11945491365051709217,13,1989
Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuits,"A Gruszka, A Hampshire, RA Barker, AM Owen","cortex 93, 178-192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15931130439953689997,12,2017
Cell therapies for Parkinson's disease: how far have we come?,"TB Stoker, RA Barker","Regenerative medicine 11 (8), 777-786",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2541453085896617119,12,2016
GSK-3,"F L'episcopo, J Drouin-Ouellet, C Tirolo, A Pulvirenti, R Giugno, N Testa, ...","Cell death & disease 7 (4), e2206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16525077200374052852,12,2016
The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders,"TP Harrower, RA Barker","Drugs of Today 40 (2), 171",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15788563557505036868,12,2004
αGal is widely expressed in embryonic porcine stem cells and neural tissue,"TP Harrower, A Richards, G Cruz, L Copeman, SB Dunnett, RA Barker","Neuroreport 13 (4), 481-485",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15711107247120191265,12,2002
C‐PE2I and ,"W Li, NP Lao‐Kaim, AA Roussakis, A Martín‐Bastida, N Valle‐Guzman, ...","Movement Disorders 33 (1), 117-127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7704064687467611600,11,2018
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease,"E Mak, L Su, GB Williams, MJ Firbank, RA Lawson, AJ Yarnall, ...","Neurobiology of aging 55, 78-90",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16014136490293659637,11,2017
Olfaction in ,"N Malek, DMA Swallow, KA Grosset, MA Lawton, CR Smith, NP Bajaj, ...","Acta Neurologica Scandinavica 134 (4), 271-276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1549952810991134168,11,2016
Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease,"JI Kim, JD Long, JA Mills, N Downing, JK Williams, JS Paulsen, S Cross, ...","European Journal of Human Genetics 23 (11), 1584",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2056986341975135888,11,2015
Dopamine stimulates epidermal growth factor release from adult neural precursor cells derived from the subventricular zone by a disintegrin and metalloprotease,"GC O’Keeffe, RA Barker","Neuroreport 22 (18), 956-958",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7959173913141919423,11,2011
Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease,"JR Evans, RA Barker","Expert opinion on pharmacotherapy 12 (8), 1249-1258",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13875864627697937354,11,2011
The neurological assessment of patients in vegetative and minimally conscious states,RA Barker,"Neuropsychological rehabilitation 15 (3-4), 214-223",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3529347755085327821,11,2005
A genome wide linkage disequilibrium screen in Parkinson’s disease,"T Foltynie, A Hicks, S Sawcer, A Jonasdottir, E Setakis, M Maranian, ...","Journal of neurology 252 (5), 597-602",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=165569775946775502,11,2005
Neurotrophic factors and neural grafts: a growing field,"RA Barker, SB Dunnett, JW Fawcett","Seminars in Neuroscience 5 (6), 431-441",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3705127996796724232,11,1993
The clinical heterogeneity of Parkinson's disease and its therapeutic implications,"JC Greenland, CH Williams‐Gray, RA Barker","European Journal of Neuroscience 49 (3), 328-338",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6112956748969102603,10,2019
Cross‐sectional and longitudinal associations of diffuse idiopathic skeletal hyperostosis and thoracic kyphosis in older men and women,"WB Katzman, N Parimi, Z Mansoori, L Nardo, DM Kado, PM Cawthon, ...","Arthritis care & research 69 (8), 1245-1252","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5110940852242182437,4462709823228489166,2199169507807950985",10,2017
Learning to be inflexible: Enhanced attentional biases in Parkinson's disease,"SJ Fallon, A Hampshire, RA Barker, AM Owen","cortex 82, 24-34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2593391343790820101,10,2016
A new approach to disease-modifying drug trials in Parkinson’s disease,"RA Barker, M Stacy, P Brundin","The Journal of clinical investigation 123 (6), 2364-2365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5041924494655246388,10,2013
The relationship between abnormalities of saccadic and manual response times in Parkinson's disease,"CA Antoniades, Z Xu, RHS Carpenter, RA Barker","Journal of Parkinson's disease 3 (4), 557-563",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18229093411635291852,10,2013
Quantitative evaluation of the human subventricular zone,"GU Höglinger, RA Barker, T Hagg, O Arias-Carrion, MA Caldwell, ...","Brain 135 (8), e221-e221",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11765124818377028459,10,2012
Role of brain imaging in early parkinsonism,"DP Breen, JB Rowe, RA Barker","BMJ 342, d638",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9013441811818623047,10,2011
No alterations in α‐synuclein gene dosage observed in sporadic Parkinson's disease,"CH Williams‐Gray, A Goris, T Foltynie, J Brown, M Maranian, A Walton, ...",Movement disorders: official journal of the Movement Disorder Society 21 (5 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13972288205323842475,10,2006
A case of stiff limb syndrome responsive to plasma exchange,"A Coles, R Barker","Journal of Neurology, Neurosurgery & Psychiatry 70 (3), 407-408",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9220199932980414331,10,2001
Adrenal grafting for Parkinson's disease: a role for substance P,R Barker,"International Journal of Neuroscience 46 (1-2), 47-51",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17027645330888357823,10,1989
Abnormalities of age-related T cell senescence in Parkinson’s disease,"CH Williams-Gray, RS Wijeyekoon, KM Scott, S Hayat, RA Barker, ...","Journal of neuroinflammation 15 (1), 166",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7117384036390429413,9,2018
Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease,"J Zhang, C Nombela, N Wolpe, RA Barker, JB Rowe","Movement Disorders 31 (8), 1163-1172",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2714303051042213792,9,2016
From molecule to clinic and community for neurodegeneration: research to bridge translational gaps,"C Brayne, RA Barker, D Harold, PG Ince, GM Savva, J Williams, ...","Journal of Alzheimer's Disease 33 (s1), S385-S396",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8055037915659684364,9,2013
Adult neurogenesis is unaffected by a functional knock-out of MHC class I in mice,"RL Goya, P Tyers, RA Barker","Neuroreport 21 (5), 349-353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12595931384921988053,9,2010
Cell-based therapies for disorders of the CNS,"SE Lazic, RA Barker","Expert Opinion on Therapeutic Patents 15 (10), 1361-1376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8000362938772162173,9,2005
Parkinson disease,FO Walker,"JAMA 293 (18), 2281-2285","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9295641757196218508,17571071289261810268",9,2005
Non-systemic vasculitic neuropathy resenting with a painful polyradiculopathy: a case report,"PD Molyneux, R Barker, PK Thomas, RHM King, DH Miller","Journal of neurology 247 (8), 645",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15953293260035319598,9,2000
Exploring causality of the association between smoking and Parkinson's disease.,"V Gallo, P Vineis, M Cancellieri, P Chiodini, RA Barker, CE Brayne, ...",OUP,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8434878039911896572,8,2018
The challenges of first-in-human stem cell clinical trials: what does this mean for ethics and Institutional Review Boards?,"RA Barker, MK Carpenter, S Forbes, SA Goldman, C Jamieson, CE Murry, ...","Stem cell reports 10 (5), 1429-1431",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=500297810148180647,8,2018
Making it personal: the prospects for autologous pluripotent stem cell-derived therapies,"NF Blair, RA Barker","Regenerative medicine 11 (5), 423-425",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14803225880296982240,8,2016
A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington’s disease,"LM Collins, SE Lazic, RA Barker","BMC neurology 14 (1), 35",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5677005328303578780,8,2014
Putative cortical dopamine levels affect cortical recruitment during planning,"SJ Fallon, A Hampshire, CH Williams-Gray, RA Barker, AM Owen","Neuropsychologia 51 (11), 2194-2201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1259416342114023063,8,2013
The clinical phenotype of juvenile Huntington’s disease,"RA Barker, F Squitieri",Juvenile Huntington's Disease: And Other Trinucleotide Repeat Disorders 39,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17552539774846008937,8,2009
Stem cell transplantation as an approach to brain repair,"RJE Armstrong, M Jain, RA Barker","Expert Opinion on Therapeutic Patents 11 (10), 1563-1582",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6294911521553569356,8,2001
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease,"BR Underwood, ZW Green-Thompson, PJ Pugh, SE Lazic, SL Mason, ...","Journal of neurology 264 (12), 2457-2463",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12131755887299594623,7,2017
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study,"DJ Hensman Moss, A Pardinas, D Langbehn, K Lo, BR Leavitt, R Roos, ...","Lancet Neurology 16 (9), 701-711",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10433607105488981726,7,2017
Autonomic dysfunction in early Parkinson's disease: results from the United Kingdom tracking Parkinson's study,"N Malek, MA Lawton, KA Grosset, N Bajaj, RA Barker, DJ Burn, T Foltynie, ...","Movement disorders clinical practice 4 (4), 509-516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=141915606201215049,7,2017
"Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK","JR Evans, G Cummins, DP Breen, T Foltynie, SL Mason, CEG Brayne, ...","J Neurol Neurosurg Psychiatry 87 (9), 1034-1036",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5194966258517932849,7,2016
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain,"ML Choi, F Begeti, RA Barker, N Kim","Hippocampus 26 (4), 517-529",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12344857708041649791,7,2016
The human cytomegalovirus non-coding Beta2. 7 RNA as a novel therapeutic for Parkinson's disease–Translational research with no translation,"E Poole, WL Kuan, R Barker, J Sinclair","Virus research 212, 64-69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12889384420124729169,7,2016
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice,"D Arsenault, J Drouin‐Ouellet, M Saint‐Pierre, P Petrou, M Dubois, J Kriz, ...","The Journal of physiology 593 (10), 2257-2278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8174591080699446093,7,2015
Parkinson's disease case ascertainment in the EPIC cohort: the NeuroEPIC4PD study,"V Gallo, C Brayne, L Forsgren, RA Barker, J Petersson, O Hansson, ...","Neurodegenerative Diseases 15 (6), 331-338",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16979383206205088137,7,2015
Antidopaminergic medication is associated with more rapidly progressive Huntington’s Disease,"J Tedroff, S Waters, RA Barker, R Roos, F Squitieri","Journal of Huntington's disease 4 (2), 131-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5472056358947452250,7,2015
Frequency and profile of mild cognitive impairment in Parkinson's disease: A multicentre meta-analysis of neuropsychological data,"D Aarsland, K Bronnick, D Weintraub, K Marder, D Burn, LM Allcock, ...","WILEY-LISS 24, S288-S289",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7548134819011964693,7,2009
Cell therapies for neurological disease–from bench to clinic to bench,"T Harrower, RA Barker","Expert opinion on biological therapy 5 (3), 289-291",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12609515159565284748,7,2005
Neural stem cell technology as a novel treatment for Parkinson's disease,"RJE Armstrong, AE Rosser, SB Dunnett, RA Barker","Parkinson's Disease, 289-307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17476304246751556265,7,2001
Cell death and diseases of the nervous system,R Barker,"Journal of neurology, neurosurgery, and psychiatry 69 (3), 407",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8112001616866014224,7,2000
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts,"H Iwaki, C Blauwendraat, HL Leonard, G Liu, J Maple-Grødem, JC Corvol, ...","Neurology Genetics 5 (4), e348",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14931769984153512465,6,2019
The motor and cognitive features of Parkinson’s disease in patients with concurrent Gaucher disease over 2 years: a case series,"LM Collins, CH Williams-Gray, E Morris, P Deegan, TM Cox, RA Barker","Journal of neurology 265 (8), 1789-1794",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12571324157650476165,6,2018
Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD study,"T Minett, L Su, E Mak, G Williams, M Firbank, RA Lawson, AJ Yarnall, ...","Journal of neurology 265 (7), 1528-1539","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12539188371231266162,14365830754797887036",6,2018
Using medical claims analyses to understand interventions for Parkinson patients,"BR Bloem, JHL Ypinga, A Willis, CG Canning, RA Barker, M Munneke, ...","Journal of Parkinson's disease 8 (1), 45-58","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14017014895248805764,1958190566205776571",6,2018
Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases,"N Malek, MA Lawton, KA Grosset, N Bajaj, RA Barker, Y Ben-Shlomo, ...","Parkinsonism & related disorders 40, 40-46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4665509002304647987,6,2017
"Formation of hippocampal mHTT aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesis","LC Schwab, K Richetin, RA Barker, N Deglon","Neurobiology of disease 102, 105-112",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12112493027629615169,6,2017
Exogenous melatonin for Parkinson’s disease:‘Waking up’to the need for further trials,"DP Breen, RA Barker","Parkinsonism & related disorders 29, 121-122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17687407851673351895,6,2016
Modelling the natural history of Huntington's disease progression,"WL Kuan, A Kasis, Y Yuan, SL Mason, AS Lazar, RA Barker, J Goncalves","J Neurol Neurosurg Psychiatry 86 (10), 1143-1149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11107377534925780374,6,2015
"What is the most promising treatment for Parkinson’s disease: genes, cells, growth factors or none of the above?","G Cummins, RA Barker","Regenerative medicine 7 (5), 617-621",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8712289986301704160,6,2012
Current understanding of the glial response to disorders of the aging CNS,"F Cicchetti, RA Barker","Frontiers in pharmacology 3, 95",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1612018387715156584,6,2012
"Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?","J Drouin-Ouellet, RA Barker",Stem cells international 2012,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7816678431700336723,6,2012
Lesions associated with cognitive impairment and dementia,"J Evans, T Revesz, RA Barker","Non-dopamine Lesions in Parkinson's Disease, 261-287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4480474808444680710,6,2011
Parkinson’s disease: Genetics and pathogenesis,TM Dawson,CRC Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18367555878938270411,6,2007
Neural transplantation therapies for Parkinson's and Huntington's diseases,"RA Barker, AE Rosser","Drug discovery today 6 (11), 575-582",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7888406284494593532,6,2001
Preparation of cell suspensions for transplantation,"RA Barker, AE Rosser, SB Dunnett","Neural Transplantation Methods, 195-205",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3116757691143726089,6,2000
The rejection of neural xenotransplants: A role for antibodies?,"RA Barker, SB Dunnett, A Richards","Transplantation 68 (8), 1091-1092",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17424241385549949909,6,1999
The heart in systemic lupus erythematosus.,RA Barker,"BMJ: British Medical Journal 299 (6693), 245",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2343000114758834909,6,1989
WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis,"K Kaiser, D Gyllborg, J Procházka, A Salašová, P Kompaníková, ...","Nature communications 10 (1), 1498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17255633855445740833,5,2019
Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease,"J Lamontagne-Proulx, I St-Amour, R Labib, J Pilon, HL Denis, N Cloutier, ...","Neurobiology of disease 124, 163-175",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12260963451431725696,5,2019
iPSC modeling of presenilin1 mutation in Alzheimer's disease with cerebellar ataxia,"L Li, JH Roh, EH Chang, Y Lee, S Lee, M Kim, W Koh, JW Chang, HJ Kim, ...","Experimental neurobiology 27 (5), 350-364",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14596733542521242363,5,2018
Novel targets for Huntington’s disease: future prospects,"SL Mason, RA Barker","Degenerative neurological and neuromuscular disease 6, 25",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16787262457679750826,5,2016
Progress in Huntington’s disease: the search for markers of disease onset and progression,"S Mason, RA Barker","Journal of neurology 262 (8), 1990-1995",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10837908784905797049,5,2015
Parkinson's disease: diagnosis and current management,"L Collins, G Cummins, RA Barker","Prescriber 26 (5), 16-23",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14558662813128023439,5,2015
Neurodegenerative disorders: the Glia way forward,"RA Barker, F Cicchetti","Frontiers in pharmacology 5, 157",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17585673897703650585,5,2014
Evaluation of PLGA nanoparticles carrying leukaemia inhibitory factor for stromal-like support of rat fetal dopaminergic cells,"S Dyson, TM Fahmy, SM Metcalfe, RA Barker","J Nanomater Mol Nanotechnol 2, 003",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13747581266484549849,5,2014
Cognitive deficits in early Parkinson’s disease: New areas of research,"SL Mason, RA Barker",Current Translational Geriatrics and Experimental Gerontology Reports 1 (1 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7628433744727547377,5,2012
Habitual versus goal-directed action control in Parkinson disease,"S Wit, RA Barker, AD Dickinson, R Cools",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14204359409632341705,5,2011
""" The eyes have it"". Saccadometry and Parkinson's disease.","RA Barker, AW Michell","Experimental neurology 219 (2), 382-384",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10587287888810997758,5,2009
No evidence for association between an MAOA functional polymorphism and susceptibility to Parkinson's disease,"C Williams-Gray, A Goris, T Foltynie, A Compston, S Sawcer, RA Barker","Journal of neurology 256 (1), 132",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18370425126586378495,5,2009
Can endogenous stem cells be stimulated to repair the degenerating brain?,"AW Michell, W Phillips, RA Barker","Journal of pharmacy and pharmacology 56 (10), 1201-1210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15262447845319834260,5,2004
Parkinson's Disease: Your Questions Answered,"T Foltynie, S Lewis, RA Barker",Elsevier Health Sciences,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10130903487418722614,5,2003
A selective tachykinin receptor agonist promotes differentiation but not survival of rat chromaffin cells in vitro,"R Barker, S Dunnett, J Fawcett","Experimental brain research 92 (3), 467-472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7059129590648636248,5,1993
Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease,RA Barker,"Nature medicine 25 (7), 1045-1053",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16077072069860754347,4,2019
Clinical and genetic characteristics of late-onset Huntington's disease,"M Oosterloo, EK Bijlsma, SMJ van Kuijk, F Minkels, EM Christine, ...","Parkinsonism & related disorders 61, 101-105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=581984128978679387,4,2019
Platelet-derived extracellular vesicles in Huntington’s disease,"HL Denis, J Lamontagne-Proulx, I St-Amour, SL Mason, A Weiss, ...","Journal of neurology 265 (11), 2704-2712",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3893223486718285798,4,2018
Regenerative therapies for Parkinson’s disease: An update,"TB Stoker, RA Barker","BioDrugs 32 (4), 357-366",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14346264052003023061,4,2018
Predicting clinical diagnosis in Huntington's disease: An imaging polymarker,"SL Mason, RE Daws, E Soreq, EB Johnson, RI Scahill, SJ Tabrizi, ...","Annals of neurology 83 (3), 532-543",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14109768099184042983,4,2018
Simple generation of a high yield culture of induced neurons from human adult skin fibroblasts,"S Shrigley, K Pircs, RA Barker, M Parmar, J Drouin-Ouellet","JoVE (Journal of Visualized Experiments), e56904",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3574408765788694195,4,2018
The peripheral inflammatory response to alpha-synuclein and bacterial toxins in Parkinson’s disease,"AJ White, RS Wijeyekoon, KM Scott, NP Gunawardana, S Hayat, ...","Frontiers in neurology 9, 946",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14661474466357640098,4,2018
Parkinson disease: Defining PD subtypes—a step toward personalized management?,"CH Williams-Gray, RA Barker","Nature Reviews Neurology 13 (8), 454",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4864975698183939325,4,2017
Voices of biotech,"I Amit, D Baker, R Barker, B Berger, C Bertozzi, S Bhatia, A Biffi, ...","Nature biotechnology 34 (3), 270",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14996911542289601782,4,2016
Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson’s Disease?,"AJ Yarnall, RA Lawson, GW Duncan, DP Breen, TK Khoo, D Brooks, ...","Journal of Parkinson's disease 5 (4), 743-747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9283949511859338297,4,2015
Cognitive follow up of a small cohort of Huntington’s disease patients over a 5 year period.,"SL Mason, R Wijeyekoon, R Swain, A Ho, EL Smith, B Sahakian, ...",PLoS currents 2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3097338409721618382,4,2010
Parkinson’s disease and 2009: recent advances,"DP Breen, RA Barker","Journal of neurology 257 (7), 1224-1228",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5883438778532050652,4,2010
CHALLENGES ASSESSING FUNCTIONAL OUTCOMES IN EARLY HUNTINGTON'S DISEASE: A20,"J Paulsen, C Wang, K Duff, R Barker, M Nance, L Beglinger, D Moser, ...",Clinical Genetics 76,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5330467622625250805,4,2009
Parkinson’s Disease: What Is It? What Causes It? And How Can It Be Cured?,"T Foltynie, AW Michell, RA Barker","Protein Misfolding in Neurodegenerative Diseases, 405-438",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8388597100953598570,4,2007
Nutritional management and dietary guidelines for cancer cachexia,J Bauer,Journal-Nutritional Management and Dietary Guidelines for Cancer Cachexia,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9613307088263386386,18127444076367679941",4,2007
The future challenges in Parkinson’s Disease,"RA Barker, T Foltynie","Journal of neurology 251 (3), 361-365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4181817964396268740,4,2004
How common is dementia with Lewy bodies?,"RA Barker, T Foltynie","Journal of Neurology, Neurosurgery & Psychiatry 74 (6), 697-698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12060393861654899686,4,2003
Parkinson's disease: the treatment options,R Barker,"Journal of neurology, neurosurgery, and psychiatry 68 (4), 538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3909444270530460768,4,2000
Delayed postanoxic encephalopathy and pseudodeficiency of arylsulphatase A,"RA Barker, DJ Dick, JI Cochius","Journal of neurology 246 (11), 1103-1104",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8801593212416448283,4,1999
Effects of surgical anaesthesia on the viability of nigral grafts in the rat striatum,"SB Dunnett, EM Torres, H Richards, RA Barker","Cell transplantation 7 (6), 567-572",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10248807152700346746,4,1998
"Immunohistochemical identification of rat adrenal cortical tissue in situ, in vitro, and in intracerebral adrenal grafts","R Barker, S Dunnett, J Fawcett","Experimental neurology 122 (1), 125-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13192360563634961812,4,1993
Metastatic non-seminomatous germ cell tumour and dermatomyositis.,"RA Barker, DC Currie, A Horwich, SG Spiro","Postgraduate medical journal 66 (771), 59-60",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16350077547071268251,4,1990
Sarawak: our elective,"P Maxwell, R Barker","Journal of the Royal Society of Medicine 82 (8), 496-497",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12516895354574405735,4,1989
Paediatric gastroenteritis in the eastern Malaysian state of Sarawak: an epidemiological and clinical study,"RA Barker, PH Maxwell, CP Hong, MC Cordery, IL Chrystie",Transactions of the Royal Society of Tropical Medicine and Hygiene 82 (6 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17910137092950549025,4,1988
Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system,"A Martín-Bastida, NP Lao-Kaim, AA Roussakis, GE Searle, Y Xing, ...",Brain,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5394490935937751359,3,2019
Platelet abnormalities in Huntington’s disease,"HL Denis, J Lamontagne-Proulx, I St-Amour, SL Mason, JW Rowley, ...","J Neurol Neurosurg Psychiatry 90 (3), 272-283",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16717113008210714316,3,2019
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease,"A Di Pardo, E Amico, A Basit, A Armirotti, P Joshi, MD Neely, R Vuono, ...","Scientific reports 8 (1), 8266",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2595836901039578777,3,2018
Spatial structure normalises working memory performance in Parkinson's disease,"SJ Fallon, D Bor, A Hampshire, RA Barker, AM Owen","Cortex 96, 73-82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4281258309822222009,3,2017
Dermal fibroblasts from patients with Parkinson’s disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations,"LM Collins, J Drouin-Ouellet, WL Kuan, T Cox, RA Barker",F1000Research 6,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11470875413544475119,6848770125751981003",3,2017
Novel nut and bolt task quantifies motor deficits in premanifest and manifest Huntington’s disease,"LM Collins, F Begeti, F Panin, AS Lazar, T Cruickshank, M Ziman, ...",PLoS currents 7,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5717517093567089990,3,2015
The central clock in patients with Parkinson disease--reply.,"A Videnovic, DP Breen, RA Barker, PC Zee","JAMA neurology 71 (11), 1456-1457",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10627446205870985537,3,2014
The challenges of administering cell-based therapies to patients with Parkinson’s disease,"J Drouin-Ouellet, RA Barker","NeuroReport 24 (18), 1000-1004",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4866072976056322155,3,2013
Clinical correlates of brain inflammation in Parkinson's disease: a PET study,"BS Simpson, N Pavese, AF Ramlackhansingh, DP Breen, RA Barker, ...","MOVEMENT DISORDERS 27, S257-S257",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16612413617922578928,3,2012
Stem cells and regenerative therapies for Parkinson’s disease,"K Farrell, RA Barker","Degenerative neurological and neuromuscular disease 2, 79",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=698014676252178318,3,2012
THE EFFECT OF ATOMOXETINE ON IMPULSIVITY IN PARKINSON'S DISEASE,"CR Housden, AA Kehagia, RA Barker, T Rittman, Y Faluyi, U Mueller, ...","JOURNAL OF PSYCHOPHARMACOLOGY 25 (8), A29-A29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6724993691180748593,3,2011
Olfactory dysfunction in Parkinson’s disease and related disorders,"RL Doty, CH Hawkes, HW Berendse, GM Halliday, RA Barker, DB Rowe","Non-dopamine lesions in Parkinson's disease 65, 91",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11443925016980948922,3,2011
Visualising disease progression on multiple variables with vector plots and path plots,"SE Lazic, SL Mason, AW Michell, RA Barker","BMC medical research methodology 9 (1), 32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6689413326717217129,3,2009
Graft outcomes influenced by co‐expression of Pax7 in graft and host tissue,"M Thomas, P Tyers, SE Lazic, RA Barker, L Beazley, M Ziman","Journal of anatomy 214 (3), 396-405",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11694389385255916366,3,2009
Microglial activation in presymptomatic Huntington's disease gene carriers: A combined C-11-PK11195 and C-11-raclopride PET study,"YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini","LIPPINCOTT WILLIAMS & WILKINS 66 (5), A134-A134",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9164199653427352450,3,2006
"Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease (vol 25, pg 157, 2005)","AJ Morton, NI Wood, MH Hastings, C Hurelbrink, RA Barker, ES Maywood","JOURNAL OF NEUROSCIENCE 25 (15), 3994-3994",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15013041903276280927,3,2005
Rapid decline in motor symptoms in HD neural transplant patients prior to surgery,"SE Lazic, RA Barker","Brain research bulletin 1 (63), 83-84",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13578977786974609857,3,2004
"Stridor, malaise, and visual loss in a woman from Sierra Leone","SE Brice, MD Oldfield, R Barker","Postgraduate medical journal 77 (911), 601-602",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10735844059722715778,3,2001
Model for basal ganglia disorders,R Barker,"Trends in neurosciences 13 (3), 93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10517102127347704602,3,1990
Trophic role of neurotransmitters,R Barker,"Trends in neurosciences 11 (12), 533",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1830775341438426706,3,1988
A professional standard for informed consent for stem cell therapies,"J Sugarman, RA Barker, RA Charo","Jama 322 (17), 1651-1652",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=754722212537713846,2,2019
Parkinson disease and growth factors—is GDNF good enough?,"A Kirkeby, RA Barker","Nature Reviews Neurology 15 (6), 312",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15117891026159441347,2,2019
Genome-wide association study of Parkinson's disease progression biomarkers in 12 longitudinal patients' cohorts,"H Iwaki, C Blauwendraat, HL Leonard, JJ Kim, G Liu, J Maple-Grødem, ...","BioRxiv, 585836",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17598006347137250914,2,2019
Data Resource Profile: The Dementias Platform UK (DPUK) Data Portal,"S Bauermeister, C Orton, S Thompson, R Barker, J Bauermeister, ...","BioRxiv, 582155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3805922852577336618,2,2019
APATHY IN HUNTINGTON’S DISEASE: a review of the current conceptualization,"RA Barker, SL Mason",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12940376354547578732,2,2018
Monocyte function in Parkinson's Disease and the impact of autologous serum on phagocytosis,"RS Wijeyekoon, D Kronenberg-Versteeg, KM Scott, S Hayat, JL Jones, ...","Frontiers in neurology 9, 870",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8987877557229669747,2,2018
Pathways to ambulatory sensitive hospitalisations for Māori in the Auckland and Waitemata regions,"C Barker, S Crengle, D Bramley, K Bartholomew, P Bolton, M Walsh, ...","Age 150, 863",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7849539089703209294,2,2016
Movement disorders and psychiatry: Five new things,"G Cummins, M Zandi, RA Barker","Neurology: Clinical Practice 5 (2), 143-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6571913842518640913,2,2015
L-dopa responsive parkinsonism secondary to a subdural haematoma,"MA Ellul, J Cross, RA Barker","Journal of Clinical Neuroscience 20 (7), 1022-1024",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4868676350480343059,2,2013
Characterising mild cognitive impairment in incident Parkinson's disease: The ICICLE-PD study: 505,"A Yarnall, D Breen, G Duncan, R Barker, D Burn",Movement Disorders 28,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13457935833811867620,2,2013
The ethical issues of trials of neural grafting in patients with neurodegenerative conditions,"RA Barker, A Coles",Oxford Handbook of Neuroethics,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17975447886324763267,2,2011
Cell therapies and Parkinson's disease: where next? Interviewed by Emily Culme-Seymour.,R Barker,"Regenerative medicine 5 (6), 857-861",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3026842360287284047,2,2010
"Associations between regional brain atrophy, executive control, and saccadic latency in Parkinson's disease and healthy ageing","R Perneczky, BCP Gosh, L Hughes, RHS Carpenter, RA Barker, JB Rowe",Alzheimer's & Dementia: The Journal of the Alzheimer's Association 6 (4 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17133813083498117092,2,2010
Neural transplantation for the treatment of Huntington’s Disease,"RA Barker, R Swain","Eur. Neurol. Rev 5, 41-45",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1873783723172140902,2,2010
Cell Therapy in Parkinson’s Disease,"RL Goya, RA Barker","Stem Cell Biology in Health and Disease, 145-154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11988954941480877356,2,2009
Saccadic latencies as a biomarker for Huntington's and Parkinson's disease,"C Antoniades, Z Xu, R Carpenter, R Barker",Movement Disorders 23,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=533045782887482767,2,2008
Neural transplants for parkinson’s disease: what are the issues?,RA Barker,"Poiesis & Praxis 4 (2), 129-143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6332700962177817661,2,2006
Weight changes in Huntington’s,"A Robbinsa, A Hoa, R Barkera","European journal of neurology 13, e7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=989472375959002641,2,2006
L-DOPA in Parkinson's disease abolishes nucleus accumbens activation during probabilistic reversal learning,"R Cools, S Lewis, L Clark, R Barker, T Robbins","JOURNAL OF COGNITIVE NEUROSCIENCE, 84-84",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16323689326965276737,2,2005
Huntington’s disease,R Barker,"Brain 127 (1), 233-234",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16334422864005877877,2,2004
Peripheral biomarkers of Parkinson's disease,"AW Michell, L Luheshi, D Fritz, RH Carpenter, MG Spillantini, RA Barker","Movement Disorders 19, S276-S276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7311092586658523741,2,2004
Right caudate dopamine storage correlates with spatial planning in Parkinson's disease,"AL Cheesman, SJG Lewis, R Barker, AM Owen, TW Robbins, DJ Brooks","Neurology 58 (7), A487-A487",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2946549423082130451,2,2002
CEREBRAL REORGANIZATION OF FUNCTION AFTER BRAIN DAMAGE. Edited by ,R Barker,"Brain 124 (7), 1471-1472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3575018056251096990,2,2001
Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease,"I Arnulf, M Vidailhet, AM Bonnet, S Descombes, C Jaillon, Y Agid, C Brefel, ...","Journal of Neurology, Neurosurgery & Psychiatry 70 (6), 812-813","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7088482884673154183,7583353010094797436",2,2001
Huntington's disease progression measured with serial [11C]-raclopride PET and the UHDRS,"N Pavese, TC Andrews, DJ Brooks, AE Rosser, RA Barker, SB Dunnett, ...","Neurology 56 (8), A385-A385",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14440846845920596916,2,2001
Cardiovascular and Interventional Radiological Society of Europe (CIRSE),J Lammer,"Annual Meeting, Barcelona","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=621362272896966396,5108714808955388253",2,1992
Sleep disorders,L Madow,Slack,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13762767591950522142,2,1987
Pro‐Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE‐PD,"S Stuart, RA Lawson, AJ Yarnall, J Nell, L Alcock, GW Duncan, TK Khoo, ...","Movement Disorders 34 (11), 1690-1698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=401721323768426886,1,2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts,"H Iwaki, C Blauwendraat, HL Leonard, JJ Kim, G Liu, J Maple‐Grødem, ...",Movement Disorders,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11908078809865768703,1,2019
Dual modulation of neuron‐specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons,"M Birtele, Y Sharma, S Kidnapillai, S Lau, T Stoker, RA Barker, ...",FEBS letters,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9777741193183073015,1,2019
L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression,"N Malek, S Kanavou, MA Lawton, V Pitz, KA Grosset, N Bajaj, RA Barker, ...",Parkinsonism & related disorders,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9561820896825879878,1,2019
Loss of FBXO7 results in a Parkinson's‐like dopaminergic degeneration via an RPL23‐MDM2‐TP53 pathway,"SRW Stott, SJ Randle, S Al Rawi, P Rowicka, R Harris, B Mason, J Xia, ...",The Journal of pathology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=853566671927378712,1,2019
The hunt for better treatments for Huntington's disease,"R Barker, SL Mason","The Lancet Neurology 18 (2), 131-133",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=210803528049640561,1,2019
Disease-Modification in Huntington’s Disease: Moving Away from a Single-Target Approach,"MP Jensen, RA Barker","Journal of Huntington's disease, 1-14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11374374457754230733,1,2019
Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington’s Disease,"MC Horton, P Nopoulos, M Nance, GB Landwehrmyer, RA Barker, ...","Journal of Huntington's disease, 1-13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2885455373263689365,1,2019
Pathological mechanisms and clinical aspects of GBA1 mutation-associated Parkinson’s disease,"TB Stoker, KM Torsney, RA Barker",Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet],https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9431091692810405481,1,2018
Outcome of cell suspension allografts in a patient with Huntington's disease,"A Maxan, S Mason, M Saint‐Pierre, E Smith, A Ho, T Harrower, C Watts, ...","Annals of neurology 84 (6), 950-956",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10185784178437221110,1,2018
Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report,"J Sugarman, RA Barker, I Kerridge, T Lysaght, G Pellegrini, D Sipp, ...","Stem cell reports 11 (5), 1021-1025",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17348481589116076895,1,2018
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation,"RA Barker, R Vuono",Elsevier,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7209561431747177132,1,2018
Dynamic and Cell-Specific DACH1 Expression in Human Neocortical and Striatal Development,"V Castiglioni, A Faedo, M Onorati, VD Bocchi, Z Li, R Iennaco, R Vuono, ...","Cerebral Cortex 29 (5), 2115-2124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13246314913092907307,1,2018
Categorising visual hallucinations in early Parkinson’s disease,"BJ Clegg, GW Duncan, TK Khoo, RA Barker, DJ Burn, AJ Yarnall, ...","Journal of Parkinson's disease, 1-7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=849486346166804375,1,2018
A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRAS,"L Bao, O Al-Assar, LF Drynan, MJ Arends, P Tyers, RA Barker, ...","Scientific reports 7, 44899",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10441087779068424835,1,2017
CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease,"SRW Stott, S Hayat, T Carnwath, S Garas, JP Sleeman, RA Barker","PloS one 12 (2), e0171748",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14947348026910311166,1,2017
GFORCE-PD still going strong in 2016,"M Parmar, J Takahashi, L Studer, RA Barker","NPJ Parkinson's disease 3, 16014",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5943072289254205689,1,2017
F11 Verbal memory in huntington’s disease: a longitudinal study,"AK Ho, RA Barker, HJ Pritchard","J Neurol Neurosurg Psychiatry 87 (Suppl 1), A52-A52",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13367010964570840593,1,2016
The role of neuroinflammation in the development of Parkinson's disease dementia,"A Kouli, R Vuono, R Barker, C Williams-Gray",Movement Disorders 31,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=116224192421551903,1,2016
Diabetes and Small Vessel Cerebrovascular Disease Influence Motor and Cognitive Features in Early Parkinson’s Disease (S19. 006),"N Malek, D Swallow, K Grosset, L Michael, S Marrinan, N Bajaj, R Barker, ...","Neurology 86 (16 Supplement), S19. 006",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7526207495743250487,1,2016
Genetic neuroimaging studies of basal ganglia disorders,"TW Robbins, JB Rowe, RA Barker","Neuroimaging Genetics: Principles and Practices, 241",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8007458989085965142,1,2016
SLEEP AND CIRCADIAN RHYTHM REGULATION IN EARLY PARKINSON'S DISEASE,"D Breen, R Vuono, U Nawarathna, K Fisher, J Shneerson, A Reddy, ...","J Neurol Neurosurg Psychiatry 86 (11), e4-e4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5439079913708711586,1,2015
Susceptibility weighted imaging to detect nigral iron accumulation in Parkinson's disease,"A Martin-Bastida, M Politis, C Loane, N Lao-Kaim, N Valle-Guzman, ...","J Neurol Neurosurg Psychiatry 86 (11), e4-e4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3566189688603087677,1,2015
Can the mutant huntingtin gene product spread from cell to cell: Evidence from neuronal allografts in Huntington's disease patients (S15. 002),"F Cicchetti, S Lacroix, G Cisbani, N Vallières, M Saint-Pierre, I St-Amour, ...","Neurology 84 (14 Supplement), S15. 002",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6193916180339587529,1,2015
The pathophysiological and prognostic heterogeneity of mild cognitive impairment in Parkinson's disease,"SE Winder-Rhodes, RA Barker, CH Williams-Gray","M. Emre, Cognitive Impairment and Dementia in Parkinson's Disease, 223-226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3750228488145711849,1,2015
Innate immunity and neurodegenerative disorders,"RA Barker, F Cicchetti",Frontiers E-books,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14278521514002908523,1,2014
J01 Improving Prediction Of Huntington Disease Onset With Clinical And Imaging Measures: A 10-year Preopective Study Of Converters,"J Paulsen, JD Long, C Ross, D Harrington, C Erwin, J Williams, ...","J Neurol Neurosurg Psychiatry 85 (Suppl 1), A65-A65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11333293611381800298,1,2014
"What have open label studies of cell based therapies for Parkinson's disease told us, if anything?",RA Barker,"Basal Ganglia 3 (4), 85-87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11090668690242137919,1,2014
GREY MATTER CORRELATIONS OF COGNITIVE IMPAIRMENT IN EARLY PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION–PARKINSON'S DISEASE …,"GW Duncan, MJ Firbank, AJ Yarnall, RA Barker, J T O'Brien, DJ Burn","J Neurol Neurosurg Psychiatry 84 (11), e2-e2","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3165840395635845947,15173170688905751578,14921497179889811504",1,2013
Grey matter and CSF amyloid in early non–demented Parkinson's disease: The incidence of cognitive impairment in cohorts with longitudinal evaluation in Parkinson's disease …,"GW Duncan, AJ Yarnall, MJ Firbank, RA Barker, J T O'Brien, DJ Burn","J Neurol Neurosurg Psychiatry 84 (11), e2-e2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15882137636699863259,1,2013
MAPT genotype and its influence on cognitive decline in Huntington's disease,"R Vuono, SE Winder-Rhodes, SJ Sawcer, RA Barker","MOVEMENT DISORDERS 27, S61-S62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17169608575700091169,1,2012
Glucocerebrosidase mutations influence the natural history of PD in a community-based incident cohort,"S Winder-Rhodes, JR Evans, M Ban, C Williams-Gray, T Foltynie, ...","MOVEMENT DISORDERS 27, S506-S507",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4529359796042227460,1,2012
The future of stem cells in neurodegenerative disorders of the central nervous system,RA Barker,"CMAJ 184 (6), 631-632",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5985575805041370179,1,2012
1154 The utility of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in Parkinson's disease,"P McColgan, J Evans, DP Breen, SL Mason, B Ghosh, T Rittman, J Rowe, ...","J Neurol Neurosurg Psychiatry 83 (3), e1-e1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9406596332432448328,1,2012
THE EFFECTS OF ENVIRONMENTAL ENRICHMENT IN A HUMAN HUNTINGTON’S DISEASE POPULATION: 237,"J Thompson, T Cruickshank, L Penailillo, W Carey-Hill, S Davies, ...",Clinical Genetics 80,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14873571087595272085,1,2011
Neurodegenerative disease: Tracking disease progress in Huntington disease,"RA Barker, SL Mason","Nature Reviews Neurology 7 (4), 192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4348808521171375721,1,2011
Neurology And Art: Willem De Kooning,"S Barker, R Barker","ACNR, 30",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=543336309847280876,1,2010
Challenges in assessment,"HM Brewer, RA Barker, OWJ Quarrell","Juvenile Huntington’s Disease and Other Trinucleotide Repeat Disorders, 181-188",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15925014793230558964,1,2009
Do different pharmacological treatments have different effects on saccadic eye movement abnormalities in Parkinson's disease?,"C Antoniades, Z Xu, R Carpenter, R Barker",Movement Disorders 24,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1548428175004873269,1,2009
Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia,"CH Williams-Gray, RA Barker","Nature Reviews Neurology 3 (5), 250",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3659206946647444435,1,2007
Cell repair in Parkinson’s disease,"G O’Keeffe, RA Barker","Future Medicine Ltd 2 (2), 209-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13775222922209639134,1,2007
Porcine neural xenotransplantation: Current status,"RA Barker, M Sayles","Restorative Therapies in Parkinson's Disease, 225-243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5894541913090510942,1,2006
An early account of brain transplantation,"AJ Larner, RA Barker","Advances in Clinical Neuroscience & Rehabilitation 5 (2), 26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18383130268017069599,1,2005
Microglial activation in presymptomatic Huntington's disease gene carriers: A C-11-PK11195 pet study,"YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini","BMJ PUBLISHING GROUP 76, ?-?",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17523238559615482713,1,2005
BEHAVIORAL/SYSTEMS/COGNITIVE-Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry,"SJG Lewis, A Dove, TW Robbins, RA Barker, AM Owen","Journal of Neuroscience 23 (15), 6351-6356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3865797857748273333,1,2003
Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report,"A Rosser, R Barker, T Harrower, C Watts, M Farrington, A Ho, R Burnstein, ...","Journal of Neurology, Neurosurgery and Psychiatry 73, 0-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6486906156563740874,1,2002
Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of prefrontal cortex and basal ganglia revealed by PET,"R Cools, E Stefanova, R Barker, T Robbins, AM Owen","Neuroimage 6 (13), 652",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16592771599793151977,1,2001
Neuroanatomy: 3D-Stereoscopic Atlas of the Human Brain,R Barker,"Journal of Neurology 247 (10), 816",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5453083357273523975,1,2000
Fifty Neurological Cases from the National Hospital.,R Barker,"Journal of neurology, neurosurgery, and psychiatry 68 (4), 538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5185372287008050176,1,2000
Biology,R BARKER,"Journal of Neurology, Neurosurgery, and Psychiatry 66 (6)",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2231063405448455369,1,1999
Factors important in the survival of dopamine neurons in intracerebral grafts of embryonic substantia nigra,"R Barker, R Fricker, SB Dunnett","Methods in Neurosciences 21, 237-252",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9895883348899221341,1,1994
Factors important in the survival and functional capacity of intracerebral adrenal and embryonic nigral grafts.,RA Barker,University of Cambridge,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1307044387931904673,1,1994
DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits,"K Solti, WL Kuan, B Fórizs, G Kustos, J Mihály, Z Varga, B Herberth, ...","Neurobiology of disease 134, 104629",,0,2020
Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease,"A Huefner, WL Kuan, SL Mason, S Mahajan, RA Barker",Chemical Science,,0,2020
123 T and B lymphocyte senescence in parkinson’s disease,"M Jensen, K Scott, M Camacho, J Greenland, A Kouli, R Wijeyekoon, ...","Journal of Neurology, Neurosurgery & Psychiatry 90 (12), e35-e35",,0,2019
Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease,"WL Kuan, K Stott, X He, TC Wood, S Yang, JCF Kwok, K Hall, Y Zhao, ...","Molecular psychiatry, 1-12",,0,2019
Association Between Toll‐Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease,"R Vuono, A Kouli, EM Legault, L Chagnon, KS Allinson, A La Spada, ...",Movement Disorders,,0,2019
Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort,"HJ Kim, S Mason, T Foltynie, S Winder‐Rhodes, RA Barker, ...",Movement Disorders,,0,2019
"ParkinsonTs Disease, Religious Belief and Spirituality","R Barker, C Redfern","The Neurology of Religion, 101",,0,2019
Senescence and inflammatory markers for predicting clinical progression in Parkinson’s Disease-the ICICLE-PD Study,"C Williams-Gray, R Wijeyekoon, R Barker",IOS Press,,0,2019
DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits,"WL Kuan, C Williams-Gray, R Barker",Elsevier,,0,2019
Progression of neuropsychiatric symptoms in Parkinson's disease: 366,"J Dlay, G Duncan, T Khoo, C Williams-Gray, D Breen, R Barker, D Burn, ...",Movement Disorders 34,,0,2019
Neuropsychological changes over the first 6 years of Parkinson's disease in the ICICLE-PD cohort: 1700,"R Lawson, G Duncan, T Khoo, D Breen, M Camacho, C Williams-Gray, ...",Movement Disorders 34,,0,2019
"The SUNRISE-PD Study, a clinical trial of AXO-LENTI-PD: a CNS-directed gene therapy for the treatment of Parkinson's Disease: 833","G Corcoran, P Korner, J Wright, Y Mo, J Benoit, K Binley, J Miskin, ...",Movement Disorders 34,,0,2019
Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory,"KL Harris, M Armstrong, R Swain, S Erzinclioglu, T Das, N Burgess, ...","cortex 119, 417-427",,0,2019
Association between TLR4 and TREM2 genetic variants and clinical progression of Huntington’s disease,"R Vuono, A Kouli, K Allinson, R Barker",Wiley-Blackwell,,0,2019
Motor complications in Parkinson’s disease: 13-year follow-up of the CamPaIGN cohort,"S Mason, S Winder-Rhodes, R Barker, C Williams-Gray",Wiley-Blackwell,,0,2019
GWAS of Parkinson’s disease clinical biomarkers in 12 longitudinal patients’ cohorts,"R Barker, R Wijeyekoon, C Williams-Gray",John Wiley & Sons Inc.,,0,2019
Pro-saccades predict cognitive decline in Parkinson’s disease: ICICLE-PD,R Barker,John Wiley & Sons Inc.,,0,2019
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson’s disease study,"MMX Tan, N Malek, MA Lawton, L Hubbard, AM Pittman, T Joseph, ...","Brain 142 (9), 2828-2844",,0,2019
A Professional Standard for Informed Consent for Stem Cell Therapies,R Barker,American Medical Association,,0,2019
IPSC MODELING OF PSEN1 MUTATION IN ALZHEIMER’S DISEASE WITH CEREBELLAR ATAXIA,"L Li, JH Roh, EH Chang, Y Lee, S Lee, M Kim, W Koh, JW Chang, HJ Kim, ...","Alzheimer's & Dementia: The Journal of the Alzheimer's Association 15 (7), P960",,0,2019
Multimodal imaging of neuromelanin and dopamine transporters in Parkinson's disease reveals asymmetrical relationships within the nigrostriatal system,"NP Lao-Kaim, A Martin-Bastida, AA Roussakis, G Searle, Y Xing, R Gunn, ...","EUROPEAN JOURNAL OF NEUROLOGY 26, 99-99",,0,2019
"The SUNRISE-PD study, a clinical trial of AXO-LENTI-PD: a lentiviral gene therapy for the treatment of Parkinson's disease","G Corcoran, P Korner, JF Wright, Y Mo, J Benoit, K Binley, JE Miskin, ...","EUROPEAN JOURNAL OF NEUROLOGY 26, 847-847",,0,2019
Functional responses to joystick movements during Parkinson's disease progression: a longitudinal fMRI study,"N Hannaway, NP Lao-Kaim, A Martin-Bastida, AA Roussakis, J Howard, ...","EUROPEAN JOURNAL OF NEUROLOGY 26, 227-227",,0,2019
Neuroanatomie et neurosciences,"RA Barker, F Cicchetti, ESJ Robinson",De Boeck Superieur,,0,2019
Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across …,"AK Ho, MC Horton, GB Landwehrmeyer, JM Burgunder, A Tennant, ...","Value in Health 22 (6), 712-720",,0,2019
Genetic risk for Parkinson’s disease and progression: an analysis of 13 longitudinal cohorts,"K Scott, R Wijeyekoon, R Barker, C Williams-Gray",,,0,2019
"Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan","OAM GW, TK Khoo, DJ Brooks, JB Rowe, RA Barker, D Burn, JT O'Brien",,,0,2019
AXO-Lenti-PD: A Second-Generation Lentiviral Gene Therapy for the Treatment of Parkinson's Disease,"G Corcoran, P Korner, F Wright, T Foltynie, K Binley, Y Lad, RA Badin, ...","MOLECULAR THERAPY 27 (4), 188-188",,0,2019
Targeting Huntingtin Expression in Patients with Huntington’s Disease,R Barker,Massachusetts Medical Society,,0,2019
RELATIONSHIP BETWEEN NEUROMELANIN AND DOPAMINE TERMINALS WITHIN THE PARKINSON’S NIGROSTRIATAL SYSTEM,R Barker,Oxford University Press,,0,2019
WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis.,"R Laguna-Goya, R Barker",Nature Publishing Group,,0,2019
Voices: The Importance of Fetal Tissue Research,"I Weissman, E Rawlins, K Jensen, R Barker, P Beltrao-Braga, B Dekel, ...","Cell Stem Cell 24 (3), 357-359",,0,2019
Hyperosmotic stress induces cell-dependent aggregation of α-synuclein,"AMC Fragniere, SRW Stott, SV Fazal, M Andreasen, K Scott, RA Barker","Scientific reports 9 (1), 2288",,0,2019
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson’s disease study.,R Barker,,,0,2019
Hyperosmotic stress induces cell-dependent aggregation of α-synuclein,"RA Barker, A Fragniere, S Stott, SV Fazal, M Andreasen, K Scott",Nature Publishing Group,,0,2019
Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study,"C Martin-Ruiz, CH Williams-Gray, AJ Yarnall, JJ Boucher, RA Lawson, ...","Journal of Parkinson's Disease, 1-14",,0,2019
Altered subcortical emotional salience processing differentiates Parkinson's patients with and without psychotic symptoms,"F Knolle, S Garofalo, R Viviani, A Justicia, AO Ermakova, H Blank, ...","medRxiv, 19010512",,0,2019
A touchscreen motivation assessment validated in Huntington’s disease patients and R6/1 model mice,"C Heath, C O'Callaghan, SL Mason, B Phillips, LM Saksida, TW Robbins, ...","Frontiers in neurology 10, 858",,0,2019
The Differential Diagnosis of Parkinson’s Disease,"JC Greenland, RA Barker",Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet],,0,2018
Tackling the Ethical Challenges Associated with Premature Delivery of Stem Cell-Based Therapies: Report of a Focus Session at the ISSCR 2018 Annual Meeting,RA Barker,Elsevier,,0,2018
"Prosavin (R), a dopamine gene therapy for advanced Parkinson's disease: 5 years phase I/II clinical update","S Palfi, JM Gurruchaga, C Watts, PC Buttery, H Lepetit, G Fenelon, ...","HUMAN GENE THERAPY 29 (12), A87-A87",,0,2018
P-221 How does end of life care and the views of stakeholders fit with the ambitions of national policy?,"R Barker, P Wilson, C Butler","BMJ Supportive & Palliative Care 8 (Suppl 2), A89-A89",,0,2018
In memory of Tom Isaacs: The epitomical mover and shaker,"L Isaacs, R Barker, E Dowd",European Journal of Neuroscience,,0,2018
Platelets Contribute to Disease Pathology in Huntington Disease,"HL Denis, J Lamontagne-Proulx, I St-Amour, SL Mason, JW Rowley, ...","NEUROTHERAPEUTICS 15 (4), 1181-1182",,0,2018
B lymphocytes may be protective in early Parkinson's disease and in an animal model of dopaminergic cell death,"K Scott, C Williams-Gray, R Wijeyekoon, S Hayat, K Hall, P Tyers, ...","MOVEMENT DISORDERS 33, S782-S783",,0,2018
Early gastrointestinal dysfunction is predictive of faster progression in Parkinson's disease,"M Camacho, J Evans, D Breen, G Cummins, R Wijeyekoon, K Scott, ...","MOVEMENT DISORDERS 33, S729-S729",,0,2018
L-Dopa responsiveness in early Parkinson's disease: Results from the United Kingdom Tracking Parkinson's study,"N Malek, S Kanavou, M Lawton, K Grosset, V Pitz, N Bajaj, R Barker, ...","MOVEMENT DISORDERS 33, S164-S164",,0,2018
A post-mortem and in vivo study of neuroinflammation and Toll like-receptors in Parkinson's disease,"A Kouli, WL Kuan, K Scott, X He, R Barker, C Williams-Gray","MOVEMENT DISORDERS 33, S805-S805",,0,2018
Developing and validating Parkinson’s Disease subtypes and their motor and cognitive progression,RA Barker,BMJ Publishing Group,,0,2018
F13 Assessment of the performance of a modified motor scale as applied to juvenile onset huntington’s disease,"MC Horton, P Nopoulos, M Nance, GB Landwehrmeyer, RA Barker, ...","Journal of Neurology, Neurosurgery & Psychiatry 89 (Suppl 1), A44-A44",,0,2018
ASSESSMENT OF THE PERFORMANCE OF A MODIFIED MOTOR SCALE AS APPLIED TO JUVENILE ONSET HUNTINGTON'S DISEASE,"MC Horton, P Nopoulos, M Nance, GB Landwehrmeyer, RA Barker, ...","JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 89, A44-A44",,0,2018
F27 Factors that influence financial vulnerability in huntington’s disease,"S Mason, WL Kuan, M Baddeley, R Barker","J Neurol Neurosurg Psychiatry 89 (Suppl 1), A49-A49",,0,2018
"J01 Effects of IONIS-HTTRX (RG6042) in patients with early huntington’s disease, results of the first htt-lowering drug trial","SJ Tabrizi, B Leavitt, B Landwehrmeyer, E Wild, C Saft, R Barker, ...","J Neurol Neurosurg Psychiatry 89 (Suppl 1), A97-A98",,0,2018
H54 Investigation of the effects of dopamine antagonist medication on cognition in huntington’s disease,"K Harris, SL Mason, R Barker","J Neurol Neurosurg Psychiatry 89 (Suppl 1), A86-A86",,0,2018
F35 The contribution of motor speed to performance on cognitive processing tasks in huntington’s disease,"L Sherlock, S Mason, R Barker","J Neurol Neurosurg Psychiatry 89 (Suppl 1), A52-A52",,0,2018
Lentiviral vectors for in vivo gene therapy,"K Mitrophanous, S Palfi, A Lauer, P Campochiaro, JM Gurruchaga, ...","HUMAN GENE THERAPY 29 (7), A3-A4",,0,2018
Functional connectivity changes in relation to dopaminergic decline in Parkinson's over time: a resting-state fMRI and 11C-PE2I PET imaging study,"W Li, NP Lao-Kaim, A Roussakis, A Martin-Bastida, N Valle-Guzman, ...","EUROPEAN JOURNAL OF NEUROLOGY 25, 345-345",,0,2018
Features of GBA-associated Parkinson’s disease at presentation in the United Kingdom Tracking Parkinson’s study (S3. 003),"N Malek, R Weil, C Bresner, M Lawton, K Grosset, M Tan, N Bajaj, ...","Neurology 90 (15 Supplement), S3. 003",,0,2018
Multimorbidity Predicts Quality of Life but not Motor Severity in Early Parkinson’s Disease,"R Gravell, GW Duncan, TK Khoo, DJ Burn, AA Sayer, RA Barker, ...","Journal of Parkinson's disease, 1-5",,0,2018
11: A longitudinal studyc‐pe2i and: A longitudinal study18: A longitudinal studyf‐dopa Pet for assessing progression rate in Parkinson's: A longitudinal study,"W Li, NP Lao‐kaim, AA Roussakis, A Martín‐bastida, N Valle‐guzman, ...","Movement Disorders 33 (1), 117-127",,0,2018
Factors That Influence Financial Decision Making in Huntington's Disease,"S Mason, WL Kuan, R Barker, M Baddeley","NEUROTHERAPEUTICS 15 (1), 253-253",,0,2018
PO088 Nigral iron susceptibility in parkinson’s disease: a longitudinal study,"A Martin-Bastida, NP Lao-Kaim, Y Xing, C Loane, AA Roussakis, ...","J Neurol Neurosurg Psychiatry 88 (Suppl 1), A34-A35",,0,2017
Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease,"R Lakshminarayana, D Wang, D Burn, KR Chaudhuri, C Galtrey, ...","NPJ Parkinson's disease 3 (1), 32",,0,2017
Longitudinal comparison of 11C-PE2I and 18F-DOPA pet for assessing severity and rate of disease progression in patients with Parkinson’s disease,"W Li, NP Lao-Kaim, A Roussakis, A Martin-Bastida, C Loane, ...","Journal of the Neurological Sciences 381, 128",,0,2017
PD and GBA mutations [version 1; referees: 1 approved with,"LM Collins, J Drouin-Ouellet, WL Kuan, T Cox, RA Barker",,,0,2017
Associations between Lifestyle Factors and Parkinson’s Disease in an Urban Sri Lankan Clinic Study,"R Wijeyekoon, V Suriyakumara, R Gamage, T Fernando, A Jayasuriya, ...",International archives of medicine 10,,0,2017
Progress towards a cell replacement therapy for Parkinson's disease,"N Blair, A Kirkeby, M Parmar, R Barker","HUMAN GENE THERAPY 28 (8), A20-A20",,0,2017
LONGITUDINAL DIFFUSION TENSOR IMAGING AS A PREDICTOR OF COGNITIVE DOMAIN DECLINE IN EARLY-STAGE PARKINSON’S DISEASE: ICICLE-PD STUDY,"T Minett, L Su, E Mak, MJ Firbank, RA Lawson, AJ Yarnall, GW Duncan, ...","Alzheimer's & Dementia: The Journal of the Alzheimer's Association 13 (7), P1353",,0,2017
THE ROLE OF TAU IN HUNTINGTON'S DISEASE,RA Barker,"Alzheimer's & Dementia: The Journal of the Alzheimer's Association 13 (7), P1220",,0,2017
LONGITUDINAL DIFFUSION TENSOR IMAGING AS A PREDICTOR OF COGNITIVE DOMAINS DECLINE IN EARLY STAGE PARKINSON’S DISEASE: ICICLE-PD STUDY,"T Minett, L Su, E Mak, GB Williams, MJ Firbank, RA Lawson, AJ Yarnall, ...","Alzheimer's & Dementia: The Journal of the Alzheimer's Association 13 (7), P61",,0,2017
Assessing longitudinal iron deposition in deep grey matter nuclei with high-pass filtered phase MR Imaging in Parkinson's disease,"AM Bastida, NP Lao-Kaim, Y Xing, C Loane, A Roussakis, ST Schwarz, ...",3rd Congress of the European-Academy-of-Neurology,,0,2017
11C-PE2I and 18F-DOPA PET imaging for assessing the severity and rate of progression in Parkinson's disease: The longitudinal study,"W Li, N Lao-Kaim, A Roussakis, A Martin-Bastida, N Valle-Guzman, ...",3rd Congress of the European-Academy-of-Neurology,,0,2017
High-Pass Filtered Phase Mr Imaging to Detect Longitudinal Motor Associations of Iron Accumulation in Parkinson's Disease,"A Martin-Bastida, N Lao-Kaim, Y Xing, C Loane, A Roussakis, S Schwarz, ...",21st International Congress of Parkinson's Disease and Movement Disorders,,0,2017
Mild cognitive impairment in newly diagnosed Parkinson's disease: a three year follow up,"R Lawson, A Yarnall, G Duncan, D Breen, T Khoo, C Williams-Gray, ...",MOVEMENT DISORDERS 32,,0,2017
Levodopa responsiveness in Parkinson's disease is significantly impaired in those with diabetes and increased vascular risk,"N Malek, M Lawton, K Grosset, N Bajaj, R Barker, Y Ben-Shlomo, D Burn, ...",21st International Congress of Parkinson's Disease and Movement Disorders,,0,2017
Serotonin-to-dopamine transporter ratios in Parkinson's dyskinesias: The longitudinal study,"AA Roussakis, N Lao-Kaim, A Martin-Bastida, N Valle-Guzman, M Politis, ...",21st International Congress of Parkinson's Disease and Movement Disorders,,0,2017
Fulfillment of International Parkinson's and Movement Disorder Society clinical diagnostic criteria for Parkinson's disease in a large cohort study of recent onset cases.,"N Malek, M Lawton, K Grosset, N Bajaj, R Barker, Y Ben-Shlomo, D Burn, ...",21st International Congress of Parkinson's Disease and Movement Disorders,,0,2017
cortical and striatal reward Processing in Parkinson’s Disease Psychosis,"S Garofalo, A Justicia, G Arrondo, AO Ermakova, P Ramachandra, ...","Frontiers in neurology 8, 156",,0,2017
Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1. 002),"G Liu, B Boot, JJ Locascio, Z Liao, D Franco, K Duong, K Page, I Jansen, ...","Neurology 88 (16 Supplement), S1. 002",,0,2017
Assessment of cerebral vascular abnormalities in Huntington’s Disease at 7Tesla,"RJ Dury, SL Mason, F Cicchetti, J Drouin-Ouellet, RA Barker, PA Gowland, ...",ISMRM,,0,2017
"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ","JB Rowe, RA Barker, DJ Burn, JT O'Brien",,,0,2017
"Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH","RA Barker, DJ Burn",,,0,2017
Effects Of Vascular Comorbidity In Parkinson's Disease,"DMA Swallow, N Malek, KA Grosset, MA Lawton, NP Bajaj, RA Barker, ...","J Neurol Neurosurg Psychiatry 87 (12), e1-e1",,0,2016
Levodopa-induced Dyskinesia In Parkinson's: A Longitudinal Pet Study,"AA Roussakis, N Lao-Kaim, A Martin-Bastida, N Valle-Guzman, ...","J Neurol Neurosurg Psychiatry 87 (12), e1-e1",,0,2016
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's,"S Loiodice, P Winlow, S Dremier, E Hanon, D Dardou, O Ouachikh, ...",,,0,2016
Large intracranial meningioma masquerading as Parkinson's disease,"M Fong, A Ghahreman, L Masters, W Huynh","J Neurol Neurosurg Psychiatry 87 (11), 1251-1251",,0,2016
Disease-Modifying Therapies in Neurodegenerative Disorders,"J DROUIN-OUELLET, RA BARKER","Neurodegenerative Diseases: Unifying Principles, 292",,0,2016
"Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14 …",L Vitillo,"REGENERATIVE MEDICINE 11 (7), 743-743",,0,2016
F8 Hippocampal abnormalities in premanifest and early stage huntington’s disease,"K Harris, S Mason, R Barker","J Neurol Neurosurg Psychiatry 87 (Suppl 1), A51-A51",,0,2016
"Coalescence of sleep EEG rhythms: effects of circadian phase, sleep history and neurodegeneration","A Lazar, Z Lazar, I Arnulf, DJ Dijk, R Barker","JOURNAL OF SLEEP RESEARCH 25, 43-43",,0,2016
O'Brien JT. Gray and white matter imaging: A biomarker for cognitive,"GW Duncan, MJ Firbank, AJ Yarnall, TK Khoo, DJ Brooks, RA Barker, ...",,,0,2016
Imaging nigrostriatal circuitry with 11C-PE2I PET and neuromelanin-sensitive MR in Parkinson's disease: T204,"AM Bastida, N Lao-Kaim, AA Roussakis, M Politis, W Li, N Valle-Guzman, ...",European Journal of Neurology 23,,0,2016
Combined imaging markers increase accuracy when predicting real life disease onset in Huntington's disease,"S Mason, R Daws, R Barker, A Hampshire",Movement Disorders 31,,0,2016
Does cognitive decline contribute to poorer quality of life in incident Parkinson's disease? A three year follow up,"R Lawson, A Yarnall, G Duncan, D Breen, T Khoo, C Williams-Gray, ...",Movement Disorders 31,,0,2016
Deletions at 22q11. 2 in idiopathic Parkinson's disease: A combined analysis of GWAS data,"KY Mok, U Sheerin, J Simon-Sanchez, A Salaka, L Chester, ...",20th International Congress of Parkinson's Disease and Movement Disorders,,0,2016
"Fractionating apathy–Effort, reward and impulsivity mechanisms in Parkinson's and Huntington's disease","C O'Callaghan, S Mason, C Williams-Gray, R Barker, B Sahakian, ...",Movement Disorders 31,,0,2016
Associations between cerebrospinal fluid proteins and cytokines in Parkinson's disease,"R Wijeyekoon, S Moore, K Farrell, D Breen, R Barker, C Williams-Gray",Movement Disorders 31,,0,2016
Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson's disease,"W Li, NP Lao-Kaim, AA Roussakis, A Martin-Bastida, C Loane, ...",Movement Disorders 31,,0,2016
Multimodal imaging assessment of nigrostriatal pathway in Parkinson's disease using 11C-PE2I PET and neuromelanin-sensitive MR,"A Martin-Bastida, NP Lao-Kaim, AA Roussakis, W Li, M Politis, ...","Movement Disorders 31, S408-S409",,0,2016
Visual hallucinations and executive dysfunction in Charles Bonnet syndrome: Preliminary findings from SHAPED,"D Ffytche, F D'Antonio, R Pinto, D Collerton, JP Taylor, D Burn, R Barker, ...",Movement Disorders 31,,0,2016
"Neuropsychiatric, personality and non-motor correlates of impulse control disorders in recent onset Parkinson's disease","D Swallow, M Lawton, K Grosset, N Malek, N Bajaj, R Barker, ...",Movement Disorders 31,,0,2016
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study,"AA Roussakis, A Martin-Bastida, N Valle-Guzman, Z Kefalopoulou, G Paul, ...",Wiley,,0,2016
367. A Dopamine Gene Therapy for Advanced PD: 4 Years Phase I/II Clinical Update,"S Palfi, JM Gurruchaga, SG Ralph, C Watts, P Buttery, H Lepetit, J Miskin, ...","Molecular Therapy 24, S147",,0,2016
The neurology community mourns the passing of Dr. John F. Kurtzke,"M Filippi, RA Barker, M Strupp","Journal of neurology 263 (3), 421-421",,0,2016
"Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ","DJ Brooks, AB Reddy, JB Rowe, RA Barker",,,0,2016
Imaging nigrostriatal circuitry with 11C-PE2I PET and Neuromelanin-sensitive MR in Parkinson’s disease,"A Martin-Bastida, NP Lao-Kaim, AA Roussakis, M Politis, W Li, ...","EAN, 2016, 953-953",,0,2016
Hallucinations in Parkinson’s Disease,"RA Barker, G Cummins","Neuropsychiatry Case Studies, 49-54",,0,2016
Cognitive neurology,"S Ahmed, I Baker, S Thompson, M Husain, CR Butler, L Kalra, J Hodsoll, ...",,,0,2016
How Can We Apply the New American Thyroid Association Treatment Guidelines for Children and Adolescents with Thyroid Cancer to Improve Patient Management? Novel Insights into …,"AJ Bauer, GL Francis, S Waguespack, D Zimmerman, S Krishnan, ...","US Endocrinology 12 (1), 39-51",,0,2016
Principal component discriminant analysis of mild cognitive impairment in Parkinson’s disease reveals early functional changes in the resting state,"LR Peraza, R Lawson, JM Firbank, A Yarnall, GW Duncan, TK Khoo, ...",Neuroinformatics 2016 INCF Conference,,0,2016
Prevalence and risk factors for orthostatic hypotension in early PD,"C McDonald, RA Lawson, GW Duncan, TK Khoo, DJ Brooks, RA Barker, ...",20th International Congress of Parkinson's Disease and Movement Disorders 31,,0,2016
Principal component discriminant,"LR Peraza, R Lawson, M Firbank, A Yarnall, GW Duncan, TK Khoo, ...",,,0,2016
REMOVED: Huntington's disease-Abnormalities of hippocampal neurogenesis and proliferation in the R6/1 mouse.,"J Pakpoor, F Begeti, R Barker",International journal of developmental neuroscience: the official journal of …,,0,2015
Cardiovascular risk and statin use in recent onset Parkinson's disease,"DMA Swallow, MA Lawton, KA Grosset, N Malek, N Bajaj, RA Barker, ...","Journal of the Neurological Sciences 357, e289",,0,2015
Variation in recent onset Parkinson’s disease: implications for pre-motor detection,"DMA Swallow, MA Lawton, KA Grosset, N Malek, CR Smith, N Bajaj, ...","Journal of the Neurological Sciences 357, e289",,0,2015
A Lentiviral Based Dopamine Gene Therapy for Advanced PD: a Phase I/II Clinical Trial,"S Palfi, JM Gurruchaga, R Scott, C Watts, P Buttery, H Lepetit, J Miskin, ...","JOURNAL OF NEUROSURGERY 123 (2), A496-A496",,0,2015
Can The Mutant Huntingtin Gene Product Spread From Cell to Cell: Evidence From Neuronal Allografts in Huntington's Disease Patients,"TB Freeman, F Cicchetti, S Lacroix, G Cisbani, N Vallieres, M Saint-Pierre, ...","JOURNAL OF NEUROSURGERY 123 (2), A525-A525",,0,2015
Nigral iron susceptibility in Parkinson's disease (PD),"AM Bastida, M Politis, C Loane, N Lao-Kaim, N Valle-Guzman, ...","EUROPEAN JOURNAL OF NEUROLOGY 22, 67-67",,0,2015
The effect of olanzapine on cognition in Huntington's disease,"L Schwab, S Mason, R Barker",Movement Disorders 30,,0,2015
Leptin and insulin; biomarkers for cognitive impairment in Parkinson's disease? ICICLE-PD 36 month interim analysis: 871,"F Johnston, R Lawson, T Khoo, A Yarnall, G Duncan, S Coleman, ...",Movement Disorders 30,,0,2015
Linguistic ability in patients with Parkinson's disease: Can it predict future memory deficits?: 898,"NV Guzman, CW Gray, R Barker",Movement Disorders 30,,0,2015
Olfaction inParkincompound and single heterozygotes in young onset United Kingdom PD patients: 1043,"N Malek, K Grosset, M Lawton, C Smith, N Bajaj, R Barker, Y Ben-Shlomo, ...",Movement Disorders 30,,0,2015
Does prolonged use of anticholinergic medication contribute to cognitive impairment in early Parkinson's disease?,"R Lawson, A Yarnall, G Duncan, D Breen, T Khoo, D Brooks, R Barker, ...",Movement Disorders 30,,0,2015
Tracking Parkinson's: A United Kingdom cohort study in Parkinson's disease,"N Malek, K Grosset, M Lawton, N Bajaj, R Barker, Y Ben-Shlomo, D Burn, ...",Movement Disorders 30,,0,2015
"Motor and non motor symptoms of a cohort of young, early onset Parkinson's disease patients enrolled in Transeuro: 3 year follow up: 339","NV Guzman, R Wijeyekoon, D Daft, R Barker",Movement Disorders 30,,0,2015
2251 Is cholesterol good or bad for your brain?–NMDARs have a say,"LP Wollmuth, R Wijesinghe, VW Tung, AJ Camp, DA Protti, MA Mathews, ...",The Journal of Physiology 593 (10),,0,2015
Characterisation Of Cognitive Decline Over 5 Years In An Incident Parkinson’s Disease Cohort: Results From The CamPaIGN Study (P6. 061),"C McAllister, C Williams-Gray, S Mason, T Foltynie, R Abbott, P Nathan, ...","Neurology 84 (14 Supplement), P6. 061",,0,2015
Motor Associations Of Iron Deposition In Patients With Parkinson’s Disease (P6. 065),"MB Antonio, M Politis, C Loane, LK Nicholas, N Valle-Guzman, ...","Neurology 84 (14 Supplement), P6. 065",,0,2015
Functional Reorganization of Resting Neural Networks are A Function of Disease Duration in Relapsing-Remitting Multiple Sclerosis,"SE Sundaram, NA Hubbard, MP Turner, LM Oasay, G Remington, ...","CLINICAL NEUROPSYCHOLOGIST 29 (3), 327-327",,0,2015
"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW","AM Owen, TK Khoo, DJ Brooks, JB Rowe, RA Barker, DJ Burn, JT O'Brien",,,0,2015
"Contents Vol. 15, 2015","C Gaig, I Ferrer, A Saiz, A Lladó, O Hansson, C Ruffmann, V Gallo, ...","Neurodegenerative Diseases 15 (6), I-IV",,0,2015
Stem cell application in neurorehabilitation,"S Jessberger, A Curt, R Barker","Oxford Textbook of Neurorehabilitation, 148",,0,2015
Copy the link,"J Drouin-Ouellet, RA Barker","Regenerative Medicine 2, 0",,0,2014
Neurodegenerative disorders: the Glia way,"RA Barker, F Cicchetti","Innate immunity and neurodegenerative disorders, 5",,0,2014
A02 Natural History In Animal Models of HD; HD Recapitulation?,R Barker,"J Neurol Neurosurg Psychiatry 85 (Suppl 1), A1-A1",,0,2014
L24 A Proposal For The Assessment Of Fitness To Drive In Patients With Huntington’s Disease,"NV Guzman, R Barker","J Neurol Neurosurg Psychiatry 85 (Suppl 1), A90-A90",,0,2014
E24 Frontostriatal Abnormalities In Huntington’s Disease: An Fmri Study,"S Mason, J Zhang, J Rowe, R Barker, A Hampshire","J Neurol Neurosurg Psychiatry 85 (Suppl 1), A45-A45",,0,2014
"G01 Verbal Learning, Recall And Recognition In Huntington’s Disease","AK Ho, H Pritchard, R Barker","J Neurol Neurosurg Psychiatry 85 (Suppl 1), A50-A50",,0,2014
J16 The Effect Of Dopamine Blockade On Cognition In Huntington’s Disease,"L Schwab, S Mason, F Begeti, R Barker","J Neurol Neurosurg Psychiatry 85 (Suppl 1), A70-A70",,0,2014
131 GASTROPARESIS SYMPTOMS IN EARLY PARKINSON'S DISEASE,"S Marrinan, N Bajaj, R Barker, Y Ben-Shlomo, A Emmanuel, T Foltynie, ...","Age and Ageing 43 (suppl_1), i36-i36",,0,2014
Anti-inflammatory drugs delay the onset of dementia in an incident Parkinson's disease cohort,"CH Williams-Gray, SL Mason, T Foltynie, RA Barker","Movement Disorders 29, S553-S553",,0,2014
Progression of mild cognitive impairment in early Parkinson's disease: The ICICLE-PD study,"A Yarnall, G Duncan, T Khoo, R Lawson, T Robbins, K Wesnes, J O'Brien, ...",Movement Disorders 29,,0,2014
Cognitive and psychiatric phenotype in a family with autosomal dominant dopa-responsive dystonia secondary to GTP cyclohydrolase deficiency: 1347,"G Cummins, R Barker","Movement Disorders 29, 494-495",,0,2014
Does quality of life vary between mild cognitive impairment subtypes in early Parkinson's disease?,"R Lawson, A Yarnall, G Duncan, T Khoo, D Breen, R Barker, D Collerton, ...",Movement Disorders 29,,0,2014
Validation of hand tapping as a longitudinal marker of disease progression in Huntington's disease: 555,"L Collins, S Lazic, R Barker",Movement Disorders 29,,0,2014
"Genetic, functional, clinical and neuropsychological confirmation of the different cognitive deficits in Parkinson's disease","C Nombela, J Rowe, S Winder-Rhodes, A Hampshire, A Owen, D Breen, ...","Movement Disorders 29, 358-359",,0,2014
The nature and significance of cerebral changes visualised on structural magnetic resonance imaging in early Parkinson's disease: 924,"G Duncan, M Firbank, A Yarnall, T Khoo, D Brooks, R Barker, D Burn, ...","Movement Disorders 29, 341-343",,0,2014
Impact of lifestyle factors on risk and age of onset of Parkinson's disease in Sri Lanka–A clinic based study: 1509,"R Wijeyekoon, R Gamage, M Fernando, A Jayasuriya, V Suriyakumara, ...","Movement Disorders 29, 552-553",,0,2014
Neuropeptides and body mass in early Parkinson's disease: Adding weight to a possible cognitive biomarker?: 1003,"A Yarnall, M Siervo, G Duncan, T Khoo, D Brooks, R Barker, D Burn","Movement Disorders 29, 371-372",,0,2014
Gastroparesis symptoms in early Parkinson's disease: Part of a wider spectrum of autonomic and non-motor dysfunction,"S Marrinan, N Malek, N Bajaj, R Barker, Y Ben-Shlomo, T Foltynie, ...",Movement Disorders 29,,0,2014
"Non motor symptoms in a cohort of young, early onset Parkinson's disease patients: 2 year follow up","V Guzman, S Moore, S Mason, D Daft, R Barker",Movement Disorders 29,,0,2014
Exploring Genetic Influences On Variation In The Phenotypic Expression Of Parkinson’s Disease.(P2. 029),"N Malek, S Marrinan, N Bajaj, R Barker, Y Ben-Shlomo, C Bresner, ...","Neurology 82 (10 Supplement), P2. 029",,0,2014
Defining Impaired Olfaction In Parkinson’s Disease: A Comparison Of Methods.(P4. 046),"K Grosset, N Malek, S Marrinan, N Bajaj, W Chan, C Banks, H Morris, ...","Neurology 82 (10 Supplement), P4. 046",,0,2014
Gold nanoparticles explore cells: Cellular uptake and their,"A Huefner, D Septiadi, BD Wilts, II Patel, WL Kuan, A Fragniere, ...",,,0,2014
"Prosavin, a dopamine gene therapy for advanced PD: phase I clinical update","S Palfi, JM Gurruchaga, GS Ralph, C Watts, P Buttery, S Scorer, H Lepetit, ...","NEUROREPORT 25 (3), 147-147",,0,2014
Human fetal dopaminergic precursor cell transplantation: LIF-nanotherapy to promote graft survival.,"SM Metcalfe, JW Zhao, P Tyers, X He, TM Fahmy, RA Barker","NEUROREPORT 25 (3), 157-157",,0,2014
"Author information: John van Geest Centre for Brain Repair, Department of Clinical Neuroscience and Neurology, University of Cambridge and Addenbrooke's Hospital, Cambridge, UK.",RA Barker,"Neuropathol Appl Neurobiol 40 (1), 1-2",,0,2014
Introduction to special issue of NAN,RA Barker,"Neuropathology and applied neurobiology 40 (1), 1-2",,0,2014
"Modelling of a nanotherapeutic"" stroma"" to deliver LIF, or XAV939, for promotion of human fetal dopaminergic cells in treatment of Parkinson's disease","JW Zhao, SC Dyson, C Kriegel, P Tyers, X He, TM Fahmy, SM Metcalfe, ...","Disease Models & Mechanisms, dmm. 015859",,0,2014
Evaluation of PLGA Nanoparticles Carrying Leukaemia Inhibitory Factor for Stromal-Like Support of Rat Fetal Dopaminergic Cells. J Nanomater Mol Nanotechnol S2: 003,"S Dyson, TM Fahmy, SM Metcalfe, RA Barker","of 6, 2",,0,2014
"Modelling of a targeted nanotherapeutic"" stroma"" to deliver LIF, or XAV939, for use in human fetal dopaminergic grafts in Parkinson's disease","JW Zhao, SC Dyson, C Kriegel, P Tyers, X He, TM Fahmy, SM Metcalfe, ...",,,0,2014
Review The Journal of Comparative Neurology Research in Systems Neuroscience,"PC Buttery, RA Barker, R Way",,,0,2014
Neurodegenerative disease: Mapping the natural history of Huntington disease,"RA Barker, SL Mason","Nature Reviews Neurology 10 (1), 12",,0,2014
FAMILY HISTORY IN YOUNG ONSET PARKINSON'S DISEASE,"N Malek, N Bajaj, R Barker, Y Ben–Shlomo, D Burn, T Foltynie, H Morris, ...","J Neurol Neurosurg Psychiatry 84 (11), e2-e2",,0,2013
Can patient-specific transdifferentiated neuronal cells help us understand the cellular pathology of Parkinson’s disease?,"J Drouin-Ouellet, LM Collins, RA Barker","Future Neurology 8 (6), 605-607",,0,2013
TRACKING PARKINSON'S (THE PROBAND STUDY)–INTERIM REPORT FROM THE FIRST 1000 CASES,"D Grosset, N Malek, N Bajaj, R Barker, D Burn, Y Ben–Shlomo, T Foltynie, ...","J Neurol Neurosurg Psychiatry 84 (11), e2-e2",,0,2013
The genetics of behavior and cognition in Parkinson's disease,"CH Williams-Gray, RA Barker",Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related …,,0,2013
88GREY MATTER CORRELATIONS OF COGNITIVE IMPAIRMENT IN EARLY PARKINSON'S DISEASE,"G Duncan, M Firbank, A Yarnall, T Khoo, J O'Brien, R Barker, D Burn",Age and Ageing 42 (suppl_3),,0,2013
Citalopram Enhances Action Inhibition Systems in Parkinson’s Disease,"Z Ye, E Altena, C Nombela-Otero, C Housden, H Maxwell, T Rittman, ...",F1000Research 4,,0,2013
Thank you Jan van Gijn,"R Barker, M Filippi, M Strupp","Journal of neurology 260 (6), 1451-1451",,0,2013
Changes in cerebral vasculature in patients with Huntington's disease: 764,"J Drouin-Ouellet, I Saint-Amour, W Kuan, M Saint-Pierre, R Barker, ...",Movement Disorders 28,,0,2013
Circadian expression profile of clock genes in early Parkinson's disease patients: 643,"R Vuono, D Breen, K Fisher, A Reddy, R Barker",Movement Disorders 28,,0,2013
The relationship between theory of mind and executive function in Parkinson's disease,"G Cummins, L Collins, S Mason, R Barker","JOURNAL OF NEUROLOGY 260, S53-S54",,0,2013
Functional MRI abnormalities on cognitive tasks in newly diagnosed PD patients-ICICLE-PD study,"C Nombela, J Rowe, A Hampshire, A Owen, D Breen, T Khoo, M Firbank, ...",Movement Disorders 28,,0,2013
"Paolo Bianco, Departmento di Medicina Sperimentale, University of Rome ‘La Sapienza’, Rome, Italy. E-mail: paolo. bianco@ uniroma1. it","P Bianco, R Barker, O Brüstle, E Cattaneo, H Clevers, GQ Daley, ...",The EMBO Journal,,0,2013
Traitement de la maladie de Parkinson par thérapie génique de la dopamine (ProSavin®) résultats d’un essai clinique de phase I,"JM Gurruchaga, GS Ralph, G Fenelon, P Remy, R Barker, ...","Revue Neurologique 169, A224-A225",,0,2013
Clinical and Cognitive Correlates of Brain Inflammation in Parkinson Disease: A PET Study (S33. 002),"B Simpson, N Pavese, A Ramlackhansingh, D Breen, R Barker, D Burn, ...","Neurology 80 (7 Supplement), S33. 002-S33. 002",,0,2013
Telomere length and cognitive impairment in early Parkinson's disease,"JJ Boucher, GW Duncan, AJ Yarnall, R Martin, RA Barker, JT O'Brien, ...",49th Annual Meeting of the Irish Neurological Association,,0,2013
The impact of motor and non-motor symptoms upon health-related quality of life in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal …,"TK Khoo, JT O'Brien, DJ Burn, AJ Yarnall, GW Duncan, RA Barker",British Geriatrics Society Spring Meeting,,0,2013
"Copeland, R. 83 Cosgrave, S. 124 Costa, J. 40 Cracknell, A. 52, 61, 62","P Crome, P Asquith, S Aston, A Attenborough, L Aye, G Babic-Illman, ...","Age and Ageing 43, i40-i42",,0,2013
Age and Ageing 2013; 42: iii29–iii30,"A Abdullah, DJ Ahearn, A Ali, M Aljaizani, K Anderson-Ranberg, T Aung, ...","Kos 1000, 81",,0,2013
Linked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments.,"C Tanner, P Brundin, RA Barker, PJ Conn, TM Dawson, K Kieburtz, ...",,,0,2013
"Author and Subject Index Vol. 63, No. 2, 2013","AA Kehagia, AA Moustafa, MM Herzallah, MA Gluck, K Foerde, EK Braun, ...","Neurodegenerative Diseases 11 (2), 112-112",,0,2013
Front & Back Matter,"AA Kehagia, AA Moustafa, MM Herzallah, MA Gluck, K Foerde, EK Braun, ...",Neurodegenerative Diseases 11 (2),,0,2013
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson’s,"SRW Stott, RA Barker",,,0,2013
ProSavin (R) a Dopamine Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial,"S Palfi, JM Gurruchaga, GS Ralph, C Watts, P Buttery, S Scorer, H Lepetit, ...","CELL TRANSPLANTATION 22 (5), 911-911",,0,2013
Journal of Neurology: ready for continued success,"RA Barker, M Filippi, M Strupp","Journal of neurology 260 (1), 1-2",,0,2013
The Addenbrooke's Cognitive Examination in Parkinsonian Disorders at Baseline and 18 Months,"T Rittman, B Ghosh, J Evans, P McColgan, D Breen, R Barker, J Rowe",Annals of Neurology 72,,0,2012
Sleep and Circadian Rhythm Disruption in Incident Parkinson's Disease-A Multimodal Analysis,"D Breen, R Vuono, K Fisher, S Nawarahtna, J Shneerson, A Reddy, ...",Annals of Neurology 72,,0,2012
The incidence of Parkinson's disease in North East England,"TK Khoo, G Duncan, AJ Yarnall, DJ Brooks, RA Barker, DJ Burn","MOVEMENT DISORDERS 27, S3-S3",,0,2012
The effects of environmental enrichment as a treatment strategy for patients with Huntington's disease,"JA Thompson, T Cruickshank, L Penailillo, S Davies, ...","MOVEMENT DISORDERS 27, S62-S62",,0,2012
Determinants of delayed diagnosis in Parkinson's disease,"D Breen, J Evans, K Farrell, C Brayne, R Barker","JOURNAL OF NEUROLOGY 259, S90-S90",,0,2012
The nature and functional impact of sleep disturbances in incident Parkinson's disease,"DP Breen, JR Evans, K Farrell, C Brayne, RA Barker","MOVEMENT DISORDERS 27, S299-S299",,0,2012
Elevated homocysteine levels predict cognitive dysfunction in an incident cohort of non-demented Parkinson's disease patients,"GW Duncan, TK Khoo, AJ Yarnall, JT O'Brien, DJ Brooks, RA Barker, ...","MOVEMENT DISORDERS 27, S13-S14",,0,2012
The CamPaIGN study of incident Parkinson's disease: Natural history over the first 10 years,"CH Williams-Gray, SL Mason, JR Evans, T Foltynie, RA Barker","MOVEMENT DISORDERS 27, S522-S523",,0,2012
Spatial planning ability in early stage Parkinson's disease patients (ICICLE-PD),"C Nombela, JB Rowe, A Hampshire, AM Owen, DP Breen, TK Khoo, ...","MOVEMENT DISORDERS 27, S28-S29",,0,2012
Depression and anxiety in incident Parkinson's disease,"TK Khoo, AJ Yarnall, G Duncan, DJ Brooks, RA Barker, JT O'Brien, ...","MOVEMENT DISORDERS 27, S275-S276",,0,2012
Tracking Parkinson's: The PRoBaND study (Parkinson's repository of biosamples and networked datasets),"N Malek, N Bajaj, R Barker, Y Ben-Shlomo, D Burn, T Foltynie, H Morris, ...","MOVEMENT DISORDERS 27, S4-S4",,0,2012
ProSavin (R) a Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial Update,"S Palfi, C Watts, JM Gurrachaga, P Buttery, S Ralph, S Deeley, H Lepetit, ...","MOLECULAR THERAPY 20, S23-S23",,0,2012
107 Longitudinal evaluation of excessive daytime sleepiness and its risk factors in Parkinson's disease,"DP Breen, JR Evans, CH Williams-Gray, SL Mason, T Foltynie, RA Barker","J Neurol Neurosurg Psychiatry 83 (3), e1-e1",,0,2012
123 In vivo evidence of COMT val158met functional polymorphism modulates different levels of dopamine turnover in Parkinson's disease: an 18F-dopa PET study,"K Wu, D O'Keeffe, M Politis, G O'Keeffe, S Bose, DJ Brooks, R Barker, ...","J Neurol Neurosurg Psychiatry 83 (3), e1-e1",,0,2012
3.156 ETHOSUXIMIDE REDUCES ALLODYNIA AND HYPERALGESIA AND POTENTIATE MORPHINE EFFECTS IN CHRONIC CONSTRICTION INJURY MODEL OF NEUROPATHIC PAIN,"HR Banafshe, G Hamidi","Parkinsonism & Related Disorders 18, S203",,0,2012
Journal of Clinical Neuroscienc e,"MA Ellul, J Cross, RA Barker",,,0,2012
Journal of Huntington’s Disease,"BR Leavitt, LM Thompson, M DiFiglia, M Levine, AB Young, E Wild, ...","Journal of Huntington's disease 1 (1), 1-1",,0,2012
New hands at the helm,RA Barker,"Journal of neurology 259 (1), 1-3",,0,2012
2.026 INCREASED MICROGLIAL ACTIVATION AND AMYLOID DEPOSITION IN PARKINSON'S DISEASE SUBJECTS AT HIGH RISK OF DEMENTIA: A PET STUDY,"BS Simpson, AF Ramlackhansingh, N Pavese, RA Barker, DP Breen, ...","Parkinsonism & Related Disorders 18, S97",,0,2012
Apathy in incident Parkinson’s disease,"TK Khoo, GW Duncan, AJ Yarnall, DJ Brooks, RA Barker, JT O'Brien, ...",The Movement Disorders Society 16th International Congress of Parkinson’s …,,0,2012
2.039 LONGITUDINAL PET STUDIES OF MICROGLIAL ACTIVATION IN HUNTINGTON'S DISEASE,"YF Tai, N Pavese, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini","Parkinsonism & Related Disorders 18, S101",,0,2012
Anti-cholinergic load: Is there a cognitive cost in early Parkinson’s disease?,"AJ Yarnall, TK Khoo, GW Duncan, RA Barker, DJ Brooks, DJ Burn",The Movement Disorders Society 16th International Congress of Parkinson’s …,,0,2012
3.206 A NOVEL NEUROPROTECTIVE THERAPY FOR PARKINSON'S DISEASE USING A VIRAL NON-CODING RNA THAT PROTECTS MITOCHONDRIAL COMPLEX I ACTIVITY,"WL Kuan, M Fletcher, E Poole, S Karniely, P Tyers, J Sinclair, RA Barker","Parkinsonism & Related Disorders 18, S204-S205",,0,2012
"The Addenbrooke's Cognitive Examination in PSP, CBD and Parkinson's disease: Baseline and 18 Months Follow up","T Rittman, BCP Ghosh, P McColgan, D Breen, J Evans, RA Barker, ...","DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 33, 234-235",,0,2012
The prion hypothesis of neurodegenerative disease spreads,R Barker,J NEUROL,,0,2011
TRANSPLANTATION AND STEM CELL RESEARCH IN MOVEMENT DISORDERS-WHERE ARE WE NOW?: MT 1-1,R Barker,European Journal of Neurology 18,,0,2011
The ethical issues of trials of neural grafting in patients with neurodegenerative,"RA Barker, A Coles","Oxford Handbook of Neuroethics, 455",,0,2011
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells,"MA Caldwell, S Scott, O Cordero-Llana, SL Maslen, JM Anderson, J Boyle, ...",,,0,2011
Erratum: AZ of Neurological Practice,"AJ Larner, AJ Coles, NJ Scolding, RA Barker","AZ of Neurological Practice, E1-E1",,0,2011
XYZ,"AJ Larner, AJ Coles, NJ Scolding, RA Barker","AZ of Neurological Practice, 806-810",,0,2011
Lesions Associated with Eye Movements,"AW Michell, RA Barker, GM Halliday","Non-dopamine Lesions in Parkinson's Disease, 50",,0,2010
Cell therapies and Parkinson's disease: where next?,"E Culme-Seymour, R Barker","REGENERATIVE MEDICINE 5 (6), 857-861",,0,2010
"Prevalence of Mutations in Parkin, PINK1, and DJ-1 in Early Onset Parkinson's Disease-A Community Based and Regional Study","JP Pearson, LL Kilarski, V Newsway, E Majounie, D Perera, ...","Movement Disorders 25, S610-S610",,0,2010
Gene and Cell Based Therapies,R Barker,Movement Disorders 25,,0,2010
J09 When do voice changes affect quality of life in Huntington's disease?,"AK Ho, J Cull, K Drake, RA Barker, SJ Tabrizi, P Lee","Journal of Neurology, Neurosurgery & Psychiatry 81 (Suppl 1), A42-A42",,0,2010
F19 Exploring the issue of swallowing in huntington's disease,"AK Ho, K Drake, J Cull, RA Barker, SJ Tabrizi, P Lee","Journal of Neurology, Neurosurgery & Psychiatry 81 (Suppl 1), A28-A29",,0,2010
F07 Expanding the response scale of the uhdrs total functional assessment: a pilot study,"AK Ho, RA Barker, R Swain, D O'Keefe","Journal of Neurology, Neurosurgery & Psychiatry 81 (Suppl 1), A24-A24",,0,2010
NEUROBIOLOGY OF AGING,"JB Rowe, L Hughes, CH WilliamsGray, S Bishop, S Fallon, RA Barker, ...","Neurobiol Aging 6, 1064-1068",,0,2010
"Associations between regional brain atrophy, executive control, and saccadic latency in Parkinson's disease and healthy aging","R Perneczky, BCP Gosh, L Hughes, RHS Carpenter, RA Barker, JB Rowe","Alzheimer's & Dementia: The Journal of the Alzheimer's Association 6 (4), S14",,0,2010
Restorative therapies for Parkinson's disease,RA Barker,"JOURNAL OF NEUROLOGY 257, S8-S8",,0,2010
Where next with cell therapies with Parkinson's disease,R Barker,第三届国际神经修复学会年会摘要集,,0,2010
P1. 193 Motor cortical excitatory plasticity is severely impaired in de novo Parkinson's disease and is improved by chronic pramipexole treatment,"A Kishore, T Joseph, S Meunier","Parkinsonism & Related Disorders 15, S78-S79",,0,2009
"P1. 218 Safety, tolerability and pharmacokinetics of Cogane™(PYM50028) studied over 28 days in healthy subjects and patients with mild-moderate Parkinson's disease","A Priestley, R Barker, R Hickling, J Locker, C Ward, P Howson, N Meyers","Parkinsonism & Related Disorders 15, S85",,0,2009
O. 059 Are growth factors the answer in Parkinson's disease?,R Barker,"Parkinsonism & Related Disorders 15, S15-S16",,0,2009
"P1. 128 The natural history of treated PD: speech, gait and posture symptoms are a sensitive index of disease progression","JR Evans, SL Mason, CH Williams-Gray, T Foltynie, RA Barker","Parkinsonism & Related Disorders 15, S61-S62",,0,2009
SPEECH MOTOR CONTROL IN HUNTINGTON'S DISEASE: F21,"A Ho, E Shirley, R Barker, S Tabrizi",Clinical Genetics 76,,0,2009
IS CINGULATE ATROPHY EVIDENT IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE? CROSS-SECTIONAL RESULTS FROM THE TRACK-HD STUDY,"N Hobbs, A Pedrick, T Pepple, R Santos, A Coleman, A Sturrock, J Barnes, ...",Clinical Genetics 76,,0,2009
CURRENT PHARMACOLOGICAL MANAGEMENT IN JUVENILE HUNTINGTON DISEASE: D05,"L Robertson, O Quarrell, H Brewer, R Barker, F Squitieri, ...",Clinical Genetics 76,,0,2009
SENTENCE COMPREHENSION IN HUNTINGTON'S DISEASE,"A Ho, E Shirley, R Barker, S Tabrizi",Clinical Genetics 76,,0,2009
DOPAMINERGIC INFLUENCE ON NEUROGENESIS IN A TRANSGENIC HUNTINGTON MOUSE MODEL,"B Wright, P Tyers, R Barker",Clinical Genetics 76,,0,2009
"Graft outcomes influenced by co-expression of Pax7 in graft and host tissue (vol 214, pg 396, 2009)","M Thomas, P Tyers, SE Lazic, MA Caldwell, RA Barker, L Beazley, ...","JOURNAL OF ANATOMY 215 (2), 225-225",,0,2009
Action Selection: the different effects of aging and Parkinson's disease,"JB Rowe, L Hughes, RA Barker",Neuroimage 47,,0,2009
The limbic-circuitry of Huntington's disease: A combined neuroimaging approach,"M Politis, N Pavese, YF Tai, L Kiferle, DJ Brooks, SJ Tabrizi, RA Barker, ...","WILEY-LISS 24, S208-S209",,0,2009
Social intelligence in Huntington's disease,"S Mason, M Armstrong, A Goodman, R Barker",Movement Disorders 24,,0,2009
Changes in tau trancription occuring as a function of tau genotype in Parkinson's disease (PD) cortex: A pathogenic substrate for the dementia of PD?,"J Evans, M Ban, S Sawcer, M Spillantini, R Barker",Movement Disorders 24,,0,2009
Could Stem Cell Research Provide a Treatment for PSP?,RA Barker,"Movement Disorders 23 (8), 1196-1199",,0,2008
BDNF val66met influences time to onset of levodopa-induced dyskinesia in Parkinson's disease: 1002,"T Foltynie, B Cheeran, C Williams-Gray, M Edwards, S Schneider, ...",Movement Disorders 23,,0,2008
Saccadic latency and manual reaction times for Parkinson's disease patients after deep brain stimulation,"C Antoniades, R Barker, R Carpenter, Y Temel",Movement Disorders 23,,0,2008
Cortical dopamine D2 receptor availability in symptomatic and asymptomatic Huntington's disease gene carriers,"N Pavese, YF Tai, R Barker, S Mason, DJ Brooks, P Piccini","NEUROLOGY 68 (12), A364-A365",,0,2007
Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency,"SFPD MRCPath, R Barker, R Way",,,0,2007
COMT val158met genotype influences attentional control in Parkinson's disease: 780,"C Williams-Gray, A Hampshire, A Owen, R Barker",Movement Disorders 22,,0,2007
Handtapping as a clinical marker for evaluating disease progression in Huntington's disease: 706,"S Mason, A Goodman, A Michell, R Barker",Movement Disorders 22,,0,2007
Sleep and circadian changes in early stage Huntington's disease,"A Goodman, J Morton, M King, J Shneerson, R Barker",Movement Disorders 22,,0,2007
"16th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR), Amsterdam, December 8-10, 2005","GJ Boer, T Eikelboom","Cell transplantation 15 (6), 541-561",,0,2006
Web Resources,"A GORIS, CH WILLIAMS-GRAY, T FOLTYNIE, DAS COMPSTON, ...","The American Journal of Human Genetics 78, 1090-1092",,0,2006
II. 1 Cognitive dysfunction in early Parkinson's Disease,"C Williams-Gray, RA Barker, R Swainson, TW Robbins","Parkinsonism & Related Disorders 12, 5",,0,2006
Cell therapies for PSP,RA Barker,"MOVEMENT DISORDERS 21 (3), 440-440",,0,2006
Brain repair: Do it yourself,"W Phillips, R Barker","The Biochemist 28 (1), 15-18",,0,2006
S. 11.03 Can cells repair the brain in Parkinson's disease?,RA Barker,"European Neuropsychopharmacology, S183",,0,2006
How many types of Parkinson's disease are there?,RA Barker,"MOVEMENT DISORDERS 21, S30-S30",,0,2006
"P08. 1 Hand tapping: A reproducible, objective marker of clinical phenotype in Huntington’s disease","A Michell, A Robbins, A Silva, S Lazic, R Barker","Clinical Neurophysiology, 168",,0,2006
Treatment resistant jerky stiff person syndrome,"TP Harrower, R Barker, J Baron, A Coles","MOVEMENT DISORDERS 21, S432-S432",,0,2006
065 IMAGING ACTIVATED MICROGLIA IN PRESYMPTOMATIC HUNTINGTON’S DISEASE GENE CARRIERS: AN 11C-PK11195 PET STUDY,"YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini","Journal Of Neurology, Neurosurgery, & Psychiatry 77 (1)",,0,2006
"P08. 1 Hand tapping: A reproducible, objective marker of clinical phenotype in Huntington# 8217s disease","A Robbins, A Silva, S Lazic, R Barker","Clinical Neurophysiology 117 (1), 168",,0,2006
Incidence of dementia and factors predicting cognitive decline in Parkinson's disease,"CH Williams-Gray, T Foltynie, DR Weinberger, C Brayne, TW Robbins, ...","WILEY-LISS 21, S580-S580",,0,2006
P115 HEALTH RELATED QUALITY OF LIFE IN HUNTINGTON’S DISEASE,"AK Ho, AOG Robbins, SJ Walters, S Kaptoge, BJ Sahakian, RA Barker","Journal Of Neurology, Neurosurgery, & Psychiatry 76",,0,2005
The Pax7 gene can be exploited to improve cell transplant therapies for neurodegenerative diseases and brain injuries,"M Thomas, L Beazley, RA Barker, MA Caldwell, M Ziman","MECHANISMS OF DEVELOPMENT 122, S134-S134",,0,2005
Transplantation for neurodegenerative disorders of the CNS is there a prefential advantage in using xenogeneic tissue?,R Barker,Xenotransplantation 12 (5),,0,2005
Neural grafting for Parkinson's disease: what? where? when and in whom?,RA Barker,"JOURNAL OF PHARMACY AND PHARMACOLOGY 57, S110-S111",,0,2005
"The Human Brain during the Third Trimester Shirley A. Bayer & Joseph Altman Andover, Hants, CRC Press, 2004 383 pp. ISBN 0-8493-1421-6, $169.95",J Cross,"British Journal of Neurosurgery 19 (3), 288-290",,0,2005
"A case of late onset sporadic Parkinson's disease with an A53T mutation in alpha-synuclein (vol 76, pg 596, 2005)","AW Michell, SK Raha, RA Barker","JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 76 (6), 892-892",,0,2005
Activated microglia accompany neuronal dysfunction in Huntington's disease. An C-11-raclopride and C-11-(R)-PK11195 PET study,"N Pavese, A Gerhard, YF Tai, AK Ho, F Turkheimer, RA Barker, DJ Brooks, ...","NEUROLOGY 64 (6), A91-A91",,0,2005
Historical notes,"W Helsen, X Liu, D Mooren, H Albrecht, B Nuttin, P Ketelaer, AS Winkler, ...",J Neurol Neurosurg Psychiatry 76 (3),,0,2005
Increased microglial activation following neural transplantation in Huntington's disease: An 11C-(R) PK11195 PET study: P112,"Y Tai, N Pavese, R Barker, S Dunnett, D Brooks, P Piccini",Movement Disorders 20,,0,2005
In vivo imaging of activated microglia by 11C-PK11195 PET. A biomarker of neuroinflammation in Huntington's disease?,"N Pavese, A Gerhard, YF Tai, AK Ho, F Turkheimer, RA Barker, A Brooks, ...",,,0,2005
The AZ of Neurological Practice,"N Scolding, D Rowe, R Barker, AJ Larner",Cambridge University Press,,0,2005
Motor heterogeneity in Parkinson's disease: An epidemiological and genetic investigation,"CH Williams-Gray, T Foltynie, RA Barker, SJ Sawcer","WILEY-LISS 20, S87-S87",,0,2005
Using stem cells to repair the Parkinsonian brain: will it work?,RA Barker,Acta Neurobiologiae Experimentalis 65 (3),,0,2005
POEZI,C Pavese,"Revistë Mikste Debatike për Çështje Shoqërore, Politikë, Kulturë Dhe Letërsi …",,0,2005
Rasagiline,R Barker,"Drugs & Aging 22 (1), 93-93",,0,2005
"NEURAL STEM CELLS FOR BRAIN AND SPINAL CORD REPAIR Tanya Zigova, Evan Snyder and Paul Sanberg, editors. 2002. Totowa (NJ) Humana Press Price 149.50.ISBN1588290034STILLLIVES …","A Coles, R Barker","Brain 127 (12), 2779-2782",,0,2004
Enhanced Metabolism in Frontotemporal Networks in Parkinson's Disease,"A Cheesman, R Barker, D Brooks",Neurology 62 (7),,0,2004
Sequential Porcine Neural Xenograft Survival,"T Harrower, D Agombar, Y Hooks, R Barker",Neurology 62 (7),,0,2004
"R. Horowoski, Y. Mizuno, CW Olanow, WH Poewe, P. Riederer, JA Stoessl, MBH Youdim (Editors) Advances in research on neurodegeneration (volume 10)",R Barker,"Human Genetics 114 (4), 400-400",,0,2004
Pseudo-neglect in Huntington's disease correlates with decreased angular gyrus density,"BJ Sahakian, JL Bradshaw, GB Williams, PJ Nestor, A Ho, RA Barker, ...","www. neuroreport. com: Lippincott Williams and Wilkins,",,0,2004
Mitochondrial DNA variation and Parkinson disease,"A Pyle, W Tiangyou, S Keers, C Lambert, D Burn, T Foltynie, R Barker, ...",Biochimica et Biophysica Acta: Bioenergetics. 6th European Meeting on …,,0,2004
Working memory ability in Parkinson's disease is associated with the COMT val (108/158) met polymorphism,"T Foltynie, TE Goldberg, SJ Lewis, AD Blackwell, B Kolachana, ...","BMJ PUBLISHING GROUP 75 (5), 804-804",,0,2004
The Chief Editors and the Editorial Board thank the individuals listed below who have referees papers submitted to the Journal of Neurol-ogy in 2004. Their critical com,"S Abrahams, J Acheson, H Ackermann, A Aguzzi, J Aharon-Peretz, ...","J Neurol 251, 1554-1556",,0,2004
Future directions: the potential for recovery and repair,"SJG Lewis, RA Barker","Neurological Rehabilitation of Parkinson's Disease, 131-146",,0,2003
The neural basis for cognitive heterogeneity in Parkinson's disease as determined by fMRI,"S Lewis, A Dove, T Robbins, R Barker, A Owen","Journal of Neurology Neurosurgery and Psychiatry 74 (3), 409-409",,0,2003
"Visual hallucinations associated with zonisamide (vol 23, pg 93, 2003)","CI Akman, HG Goodkin, DP Rogers, JJ Riviello","PHARMACOTHERAPY 23 (2), 270-270",,0,2003
CognitiveImpairmentsinEarlyParkinson’sDiseaseAre AccompaniedbyReductionsinActivityinFrontostriatal NeuralCircuitry,"SJG Lewis, A Dove, TW Robbins, RA Barker, AM Owen","age 5, 10cognitivelyunimpairedpatients",,0,2003
Long term survival of porcine expanded neural precursors in the rat model of Parkinson's disease.(ABN Abstracts),"T Harrower, E Ratcliffe, A Richards, S Dunnett, R Barker","Journal of Neurology, Neurosurgery and Psychiatry 73 (2), 231-232",,0,2002
Neurogenesis in the adult brain in Huntington's disease.,"RJE Armstrong, A van Dellen, EL Ratcliffe, P Tyers, AJ Hannan, ...","EXPERIMENTAL NEUROLOGY 175 (2), 437-437",,0,2002
Widespread migration of human expanded neural precursors in the 6-OHDA model of Parkinson's disease.,"M Jain, CB Hurelbrink, RJE Armstrong, A Rosser, RA Barker","Experimental Neurology 175 (2), 431-432",,0,2002
Human T cell responses to primary porcine neural tissue and porcine expanded neural precursors.,"TP Harrower, A Dorling, RA Barker","EXPERIMENTAL NEUROLOGY 175 (2), 444-444",,0,2002
Extensive migration of neural cells from primary striatal xenografts,"CB Hurelbrink, RJE Armstrong, SB Dunnett, A Rosser, RA Barker","Experimental Neurology 175 (2), 426-427",,0,2002
The heterogeneity of idiopathic Parkinson’s disease,RA Barker,,,0,2002
Unilateral transplantation of human primary fetal,"DK Menon, JH Gillard, J Pickard, SB Dunnett, AE Rosser, RA Barker, ...","J Neurol Neurosurg Psychiatry 73, 678-685",,0,2002
A genome-wide linkage dysequilibrium screen for Parkinson's disease,"T Foltynie, SJ Sawcer, SJ Lewis, A Jonasdottir, A Hicks, RA Barker","WILEY-LISS 17, S127-S127",,0,2002
Cortical dopamine D2 receptor dysfunction in Huntington's disease,"N Pavese, AE Rosser, DJ Brooks, RA Barker, SB Dunnett, P Piccini","MOVEMENT DISORDERS 17, S318-S318",,0,2002
Specifying the executive deficit in Parkinson's disease; A combined behavioural and event related fMRI study.(Proceedings),"SJG Lewis, A Dove, R Cools, TW Robbins, RA Barker, AM Owen","Journal of Neurology, Neurosurgery and Psychiatry 72 (1), 140-141",,0,2002
Getting to the heart of dementia,R BARKER,"Journal of neurology, neurosurgery, and psychiatry 71 (5), 574",,0,2001
Neural xenotransplantation: Ready for the clinic?,"T Harrower, R Barker","NeuroReport 12 (12), A71",,0,2001
Neural transplants for neurodegenerative diseases: a fading dream?,R Barker,"Journal of Neurology, Neurosurgery, & Psychiatry 71 (1)",,0,2001
"Proceedings of the Annual Meeting of the British Neuropsychiatry Association, the Institute of Child Health, central London, 15-16 February 2001","M GEORGE, J ROTHWELL, R BARKER, S ZEKI, D FFYTCHE, ...","Journal of neurology, neurosurgery, and psychiatry 71 (1), 138",,0,2001
MHC and α Gal Expression in Porcine Fetal Neural Tissue,"T Harrower, G Cruz, L Copeman, A Richards, S Dunnett, R Barker","Clinical Science 100 (s44), 13P-13P",,0,2001
Disorders of the basal ganglia,"R Barker, A Rosser","Contemporary Treatments in Neurology, 59",,0,2001
"Faingold, Carl L., 147 Fields, Raymond L., 190, 255","SH Fox, J Aijón, JR Alonso, F Amaya, JA Amico, JMH Anneser, R Arévalo, ...","Experimental Neurology 171, 425",,0,2001
Scheduling antiretroviral drug doses in health care institutions.,"DP Rogers, MF Murray","Pharmacotherapy 20 (12), 1528-1528",,0,2000
Neural transplantation: an introduction,R Barker,"Journal of neurology, neurosurgery, and psychiatry 69 (5), 707",,0,2000
The genesis of neuroscience,R Barker,"Journal of neurology, neurosurgery, and psychiatry 69 (3), 407",,0,2000
Advances in research on neurodegeneration,R BARKER,"Journal of Neurology, Neurosurgery & Psychiatry 68 (2), 256-256",,0,2000
A fourth ventricular papilloma presenting with transient autonomic failure,"R Nicholas, R Barker, P Rudge","Journal of neurology 246 (9), 844-846",,0,1999
Embryonic porcine nigral grafts in an animal model of Parkinson's disease,"R BARKER, E RATCLIFFE, A RICHARDS, S DUNNETT","Journal of Neurology, Neurosurgery, and Psychiatry 67 (2)",,0,1999
Biology: Brain and Behaviour—The Senses and Communication,R Barker,"Journal of Neurology, Neurosurgery & Psychiatry 66 (6), 807-807",,0,1999
Diagnosis and Management of Parkinson's Disease,R Barker,"Journal of neurology, neurosurgery, and psychiatry 66 (1), 124",,0,1999
Foundations of Neurobiology,R BARKER,"Journal of neurology, neurosurgery, and psychiatry 65 (6), 959",,0,1998
Foundation of Neurobiology,R Barker,"Journal of Neurology, Neurosurgery and Psychiatry 65 (6), 960",,0,1998
Clinical Neurology-Parkinsonism.,R Barker,"Journal of Neurology, Neurosurgery & Psychiatry 65 (6), 959-959",,0,1998
The Molecular and Genetic Basis of Neurological Disease.,R Barker,"Journal of neurology, neurosurgery, and psychiatry 65 (5), 806",,0,1998
An unusual cause for a painful diplopia.,"RA Barker, PH Molyneux, P Riordan-Eva, IF Moseley, DH Miller, ...","Postgraduate medical journal 74 (869), 177",,0,1998
Peripherally inserted central catheters for ambulatory 5FU chemotherapy: A nurse led clinic.,"V Aston, C Barker, A Brewster, TS Maughan","BRITISH JOURNAL OF CANCER 78, 40-40",,0,1998
The Basal Ganglia V Advances in Behavioural Biology Volume 47.,R Barker,"Journal of Neurology, Neurosurgery & Psychiatry 63 (5), 699-699",,0,1997
"Clinical Disorders of Balance, Posture and Gait",R Barker,"Journal of neurology, neurosurgery, and psychiatry 63 (3), 415",,0,1997
"Clinical Disorder of Balance, Posture and Gait",R Barker,"Journal of Neurology, Neurosurgery and Psychiatry 63 (3), 416",,0,1997
Localisation in Clinical Neurology,R Barker,"Journal of neurology, neurosurgery, and psychiatry 62 (1), 106",,0,1997
Negative Motor Phenomena.(Advances in Neurology Vol. 67),R Barker,"Journal of neurology, neurosurgery, and psychiatry 61 (2), 235",,0,1996
Motor Activity and Movement Disorders,R Barker,"Journal of neurology, neurosurgery, and psychiatry 61 (1), 122",,0,1996
Supplementary Sensorimotor Area,R Barker,"Journal of neurology, neurosurgery, and psychiatry 61 (1), 124",,0,1996
Neurotransmitter Release and its Modulation,R Barker,"Journal of neurology, neurosurgery, and psychiatry 60 (5), 595",,0,1996
Motor Neuron Disease. Biology and Management,R Barker,"Journal of neurology, neurosurgery, and psychiatry 60 (5), 594",,0,1996
Research Journals,JA Moore,"Chemical & Engineering News 74 (18), 4-&",,0,1996
Advances in Behavioural Biology,R Barker,"Journal of Neurology, Neurosurgery & Psychiatry 60 (4)",,0,1996
Blue Books of Practical Neurology Movement Disorders 1 and 2 Reissue,R Barker,"Journal of neurology, neurosurgery, and psychiatry 60 (4), 466",,0,1996
Advances in Behavioural Biology: Volume 43. Neurotransmitters in the human brain,R Barker,"Journal of neurology, neurosurgery, and psychiatry 60 (4), 468",,0,1996
The Comprehensive Management of Parkinson's Disease,R Barker,"Journal of neurology, neurosurgery, and psychiatry 60 (2), 248",,0,1996
Etiology of Parkinson's Disease,R Barker,"Journal of neurology, neurosurgery, and psychiatry 60 (1), 125",,0,1996
Medical Neurosciences,R Barker,"Journal of neurology, neurosurgery, and psychiatry 59 (6), 663",,0,1995
Therapy of Parkinson's Disease. Revised and Expanded,R Barker,"Journal of neurology, neurosurgery, and psychiatry 59 (6), 663",,0,1995
Age-Related Dopamine-Dependent Disorders,R Barker,"Journal of neurology, neurosurgery, and psychiatry 59 (3), 344",,0,1995
Toxin-Induced Models of Neurological Disorders,R Barker,"Journal of neurology, neurosurgery, and psychiatry 59 (1), 109",,0,1995
Bailliere's Clinical Neurology. Genetics In Neurology,R Barker,"Journal of neurology, neurosurgery, and psychiatry 58 (6), 768",,0,1995
The Basal Ganglia IV. New Ideas and Data on Structure and Function,R Barker,"Journal of neurology, neurosurgery, and psychiatry 58 (3), 396",,0,1995
Current Concepts in Parkinson's Disease Research,R Barker,"Journal of neurology, neurosurgery, and psychiatry 58 (3), 396",,0,1995
Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.,R Barker,"Journal of neurology, neurosurgery, and psychiatry 55 (6), 525",,0,1992
"Neural mechanisms in disorders of movement|(Current Problems in Neurology Vol. 9). Edited by AR Crossman and MA Sambrook. John Libbey, London (1989) xi+ 455 pp.£ 38.00",R Barker,"Neuroscience 37 (2), 569-570",,0,1990
Health of the elderly,"NA Apt, RA Barker, JG Evans, B Havens, MJ Hirschfeld, RL Kane, ...","World Health Organization-Technical Report Series, 1-97",,0,1989
Autoimmune Mechanisms in Parkinson's Disease: A Reply,R Barker,"International Journal of Neuroscience 48 (3-4), 373-375",,0,1989
"Search worldwide, life-sciences literature","A Videnovic, AS Lazar, RA Barker, S Overeem",,,0,0
"Sleeman I, Aspray T, Lawson RA, Coleman S, Duncan GW, Khoo TK","I Schoenmakers, R Barker, R Rochester, DJ Burn, AJ Yarnall",,,0,0
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain,"T Piroth, S Yang, M Parmar, G Nikkhah, J Hjerling-Lefer, O Lindvall, ...",,,0,0
Social intelligence in Huntington's disease: We-109,"S Mason, M Armstrong, A Goodman, R Barker",Movement Disorders 24,,0,0
Search Site,"C Barker, S Crengle, D Bramley, K Bartholomew, P Bolton, M Walsh, ...",,,0,0
5 th World Parkinson Congress 2019 Committee Members,"R Barker, M Barretto, P Davies, CG Goetz, T Hague, N Hattori, Y Mizuno, ...",,,0,0
"Our thanks to all those who have helped with this issue. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity …","T Ali, B Avery, J Badaut, R Barker, W Becker, D Blacker, L Carey, L Collins, ...",,,0,0
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells,"SA Scott, O Cordero-Llana, SL Maslen, JM Anderson, J Boyle, ...",,,0,0
have normal GCase activity and autophagy compared to patients with PD and GBA mutations [version 2; referees: 2,"LM Collins, J Drouin-Ouellet, WL Kuan, T Cox, RA Barker",,,0,0
Search Site,"VL Chow, JY Chan",,,0,0
"† Equal contributors 1 John van Geest Centre for Brain Repair, Cambridge, UK. 2 Faculty of Medical Sciences, Anglia Ruskin University, Cambridge, UK 3 School of Medical …","FBMB BChir, RA Barker",,,0,0
"Our thanks to those who have helped with this issue of Expert Review of Neurotherapeutics. Listed below are the authors, referees and others who have kindly given their time …","CA Antoniades, A Antonini, M Asanuma, K Ashe, J Ashford, RA Barker, ...",,,0,0
Accurate Predictive Models of Atomoxetine’s and Citalopram’s Effect on Motor Inhibition in Parkinson’s Disease,"Z Ye, CL Rae, C Nombela, T Ham, T Rittman, PS Jones, PV Rodríguez, ...",,,0,0
A novel combinational approach of micro-stimulation and bioluminescence imaging to study the mechanisms of action of deep brain stimulation in mice,"D Arsenault, J Drouin-Ouellet, M Saint-Pierre, P Petrou, M Dubois, J Kriz, ...",,,0,0
Topological disorganisation of structural networks in Parkinson’s disease with mild cognitive impairment: ICICLE-PD study,"E Mak, L Su, G Williams, M Firbank, R Lawson, A Yarnall, G Duncan, ...",,,0,0
Dopamine and Huntington’s,"LC Schwab, SN Garas, J Drouin-Ouellet, SL Mason, SR Stott, RA Barker",,,0,0
帕金森病的神经嫁接: 挑战与展望,"TB Stoker, NF Blair, RA Barker","中国神经再生研究 (英文版) 12 (3), 389-392",,0,0
"Scientific Production ISI Web of Knowledge Indexed Publications with an IF* TIF: 95,495** MIF: 7,958","R Ribosa-Nogue, A Gironell, J Pagonabarraga, C Villa-Bonomo, ...","Neurology 79 (23), 2222-2223",,0,0
–SUGGESTED READINGS,"T Foltynie, CE Brayne, TW Robbins, RA Barker, NL Graham, TH Bak, ...","Movement Disorders 23, 837-844",,0,0
Stem Cell Therapy for Neurodegenerative Diseases,"E Cattaneo, A Björklund, IT Repubblica, C Sabine, R Barker, T Isaacs, ...",,,0,0
GENE AND CELL THERAPIES FOR PARKINSON’S DISEASE-WHERE IS IT ALL GOING?,RA Barker,,,0,0
Vol. 2 nº 2-Apr/May/Jun de 2008,"HJ Wear, CJ Wedderburn, E Mioshi, CH Williams-Gray, SL Mason, ...",,,0,0
Time on timing: dissociating premature responding from interval sensitivity in Parkinson’s disease Supplementary Material,"J Zhang, C Nombela, N Wolpe, RA Barker, JB Rowe",,,0,0
ACNR,"NS Ward, K Kelly, F Brander, SA Sajjadi, J Brown, RA Barker, AJ Larner",,,0,0
"Neuropsychiatry Association, the Institute of Child Health, central London, 15—16 February 2001",R BARKER,,,0,0
Mechanisms of Cognitive Flexibility in Parkinson's Disease: Role of Dopamine,"R Cools, R Barker, BJ Sahakian, TW Robbins",,,0,0
Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes,"A LEES, R Barker, J Duncan",Lancet (1989) i: 675 (letter),,0,0
"Our thanks to those who have helped with this issue of Expert Review of Neurotherapeutics. Listed below are the authors, referees and others who have kindly given their time …","S Akhondzadeh, D Alkon, S Auvin, Y Bai, H Bernstein, A Beydoun, ...",,,0,0
Search the Site,"R Nader, JA Page, J Dukeminier Jr, IM Heyman, D Haydel, DU Smith, ...",,,0,0
"Pax7 Establishes Tectal Polarity and Regulates Expression of the Axonal Guidance Cue, Ephrin-A2","M Ziman, M Thomas, S Lazic, R Barker, L Beazley",,,0,0
